To see the other types of publications on this topic, follow the link: G protein coupled receptor (GPCR).
Dissertations / Theses on the topic 'G protein coupled receptor (GPCR)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'G protein coupled receptor (GPCR).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
1
Sheng, Yinglun. "G protein signaling and G protein coupled receptor (GPCR) pathway in Xenopus oocyte maturation." Thesis, University of Ottawa (Canada), 2005. http://hdl.handle.net/10393/29262.
Full textAbstract:
Xenopus laevis oocytes are physiologically arrested at the first meiotic prophase. Progesterone reinitiates meiosis (maturation) through inhibition of an oocyte adenylyl cyclase (AC) and reduction of intracellular cAMP. However, the mechanism by which progesterone regulates AC activity and cAMP level still remains unclear.
In this thesis, I summarize work I conducted that collectively helps elucidate how high levels of cAMP might be achieved in G2 arrested oocytes. In Chapter 2, I describe our finding that inhibiting endogenous G-protein betagamma subunits, through the use of two structurally distinct Gbetagamma scavengers, causes hormone-independent oocyte maturation. In contrast, overexpression of Xenopus Gbeta1, alone or together with bovine Ggamma2, inhibits progesterone-induced oocyte maturation. These results for the first time implicate that an endogenous G protein coupled receptor system releases a Gbetagamma complex as the dominant meiosis inhibitor.
Chapter 3 describes my research aiming to reveal the identity of the oocyte AC responsible for generating meiosis-inhibiting cAMP. I provide further evidence here that the ability of Gbetagamma to inhibit meiosis is attributed to the activation of an endogenous AC, rather than other possible Gbetagamma effectors. Through molecular cloning and biochemical characterization, I discovered that the likely AC candidate is Xenopus AC7, an isoform that is activated by Gbetagamma, but only in the presence of GTP-bound Gsalpha. The identification of xAC7 suggests that the maintenance of high levels of cAMP may require the cooperation of Gsalpha and Gbetagamma.
Finally, in Chapter 4, I describe our efforts in identifying the GPCR(s) responsible for activating the cAMP signaling in prophase-arrested oocytes. A screening of known antagonists of GPCR(s) led to the identification of ritanserin, a potent antagonist of serotonin receptors, as a potent maturation inducer in Xenopus oocytes. Pharmacological and molecular studies, however, have ruled out the involvement of a known serotonin receptor in meiosis arrest. Instead, the most likely candidate is a "constitutively activated" GPCR that bears structural similarities to Xenopus serotonin receptor 7.
2
Park, Jung Hee. "Crystal structure of ligand-free G-protein-coupled receptor opsin." Doctoral thesis, Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2010. http://dx.doi.org/10.18452/16049.
Full textAbstract:
Rhodopsin ist als Sehpigment der Photorezeptorzellen einer der am aktivsten untersuchten GPCRs. Es besteht aus dem Apoprotein Opsin und dem inversen Agonisten 11-cis-Retinal. Der inaktivierende Ligand ist in der sieben Transmembran- Helix (TM)-Struktur des Rezeptors kovalent gebunden und muss durch Licht cis/trans-isomerisiert werden, um den Rezeptor zu aktivieren. Der aktivierte Rezep-tor katalysiert den Nukleotidaustausch im G-Protein und zerfällt innerhalb von Minuten in Opsin und all-trans-Retinal. Das visuelle Pigment wird dann durch erneute Beladung des Opsins mit 11-cis-Retinal wieder hergestellt. In der vorliegenden Arbeit wird die erfolgreiche Kristallisation des nativen Opsins aus der Stäbchenzelle der Rinderretina und die Bestimmung der Proteinstruktur bei 2.9 Å Auf-lösung dargestellt. Im Vergleich zur bekannten Struktur des inaktiven Rhodopsins zeigt Opsin deutliche Strukturänderungen in den konservierten E(D)RY und NPxxY(x)5,6F Regionen und in TM5-TM7. Auf der intrazellulären Seite ist TM6 ca. 6-7 Å nach außen gekippt, während die TM5 Helix verlängert und näher zu TM6 verschoben ist. Durch die strukturellen Änderungen, von denen einige einem aktiven GPCR Zustand zugeschrieben werden können, wird die leere Retinalbindungstasche reorganisiert, um zwei Öffnungen für Aus- und Eintritt von Retinal bereitzustellen. Die Struktur von Opsin liefert neue Erkenntnisse zur Bindung von hydrophoben Liganden an GPCRs, zur GPCR-Aktivierung und zur Signalübertragung auf das G-Protein.Rhodopsin as the visual pigment in photoreceptor cells is one of the most actively studied GPCRs. It consists of the apoprotein opsin and the inverse agonist, 11-cis-retinal. The inactivating ligand is bound in the seven-transmembrane helix (TM) bundle and cis/trans-isomerized by light to activate the receptor. The active receptor state is capable of catalyzing nucleotide exchange in the G protein and decays within minutes into opsin and all-trans-retinal. The visual pigment is then restored by reloading opsin with new 11-cis-retinal. In the present work, the successful crystallization of native opsin from bovine retinal rod cells and determination of the protein structure to 2.9 Å resolution is presented. Compared with the known structure of inactive rhodopsin, opsin displays prominent structural changes in the conserved E(D)RY and NPxxY(x)5,6F regions and TM5-TM7. At the cytoplasmic side, TM6 is tilted outwards by 6-7 Å, whereas the helix structure of TM5 is more elongated and close to TM6. These structural changes, of which some are attributed to an active GPCR state, reorganize the empty retinal binding pocket to disclose two openings for exit and entry of retinal. The opsin structure thus sheds new light on binding of hydrophobic ligands to GPCRs, GPCR activation and signal transfer to the G protein.
3
Younkin, Jason W. "Allosteric Effects of G-Protein Coupled Receptor Heteromerization: Relevance to Psychosis." VCU Scholars Compass, 2016. http://scholarscompass.vcu.edu/etd/4457.
Full textAbstract:
G-protein coupled receptors (GPCRs) implicated in disease are the predominant pharmaceutical targets. Growing evidence suggests that GPCRs form homo- and heteromeric complexes, resulting in allosteric functional changes. Ligands targeting one receptor can alter the function of the other receptor or receptors. Knowledge of these functional changes will provide unique opportunities to treat diseases. We examined two GPCR heteromers implicated in psychosis: mGlu2R-5HT2AR and D2R-5HT2AR. Using whole-cell patch clamp, we studied HEK-293 cells stably transfected with mGlu2R and 5HT2AR. Maximal heteromer formation allows inverse agonists to increase the G-protein activity of the opposite receptor, while sub-maximal heteromer formation does not. However, similar results are obtained in sub-maximal heteromer cells by applying a combination of a mGlu2R synthetic agonist with a 5HT2AR anti-psychotic drug. These results confirm our oocyte results, now in a mammalian cell line. Using two-electrode voltage clamp, we also investigated the allosteric changes upon heteromerization of D2R-5HT2AR in oocytes injected with appropriate cRNAs. Heteromer formation in the presence of dopamine or serotonin results in an increase in G-protein activity of each receptor while the simultaneous presence of both neurotransmitters further increases the G-protein activity. The addition of synthetic agonists or anti-psychotics decreases the G-protein activity of the opposite receptor while agonizing or antagonizing its target receptor, respectively. Maximal allosteric effects upon D2R-5HT2AR formation only occur at a specific cRNA injection ratio, but partial effects exist at other ratios. Our data suggest that allosteric functional changes upon heteromerization are physiologically relevant and are mostly different when comparing mGlu2R-5HT2AR to D2R-5HT2AR.
4
Kumas, Gozde. "Detecting G-protein Coupled Receptor Interactions Using Enhanced Green Fluorescent Protein Reassembly." Master's thesis, METU, 2012. http://etd.lib.metu.edu.tr/upload/12614136/index.pdf.
Full textAbstract:
The largest class of cell surface receptors in mammalian genomes is the superfamily of G protein-coupled receptors (GPCRs) which are activated by a wide range of extracellular responses such as hormones, pheromones, odorants, and neurotransmitters. Drugs which have therapeutic effects on a wide range of diseases are act on GPCRs. In contrast to traditional idea, it is recently getting accepted that G-protein coupled receptors can form homo- and hetero-dimers and this interaction could have important role on maturation, internalization, function or/and pharmacology.
Bimolecular fluorescence complementation technique (BiFC)is an innovative approach based on the reassembly of protein fragments which directly report interactions. In our study we implemented this technique for detecting and visualizing the GPCR interactions in yeast cells. The enhanced green fluorescent protein (EGFP) fractionated into two fragments at genetic level which does not possess fluorescent function. The target proteins which are going to be tested in terms of interaction are modified with the non-functional fragments, to produce the fusion proteins. The interaction between two target proteins, in this study Ste2p receptors which are alpha pheromone receptors from Saccharomyces cerevisiae, enable the fragments to come in a close proximity and reassemble. After reassembly, EGFP regains its fluorescent function which provides a direct read-out for the detection of interaction. Further studies are required to determine subcellular localization of the interaction. Moreover, by using the fusion protein partners constructed in this study, effects of agonist/antagonist binding and post-translational modifications such as glycosylation and phosphorylation can be examined. Apart from all, optimized conditions for BiFC technique will guide for revealing new protein-protein interactions.
5
Sherrill, Joseph D. "Functional Analysis of the Murine Cytomegalovirus G Protein-coupled Receptor M33." University of Cincinnati / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1225745444.
Full text
6
Bahena, Silvia. "Computational Methods for the structural and dynamical understanding of GPCR-RAMP interactions." Thesis, Uppsala universitet, Institutionen för biologisk grundutbildning, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-416790.
Full textAbstract:
Protein-protein interaction dominates all major biology processes in living cells. Recent studies suggestthat the surface expression and activity of G protein-coupled receptors (GPCRs), which are the largestfamily of receptors in human cells, can be modulated by receptor activity–modifying proteins (RAMPs). Computational tools are essential to complement experimental approaches for the understanding ofmolecular activity of living cells and molecular dynamics simulations are well suited to providemolecular details of proteins function and structure. The classical atom-level molecular modeling ofbiological systems is limited to small systems and short time scales. Therefore, its application iscomplicated for systems such as protein-protein interaction in cell-surface membrane. For this reason, coarse-grained (CG) models have become widely used and they represent an importantstep in the study of large biomolecular systems. CG models are computationally more effective becausethey simplify the complexity of the protein structure allowing simulations to have longer timescales. The aim of this degree project was to determine if the applications of coarse-grained molecularsimulations were suitable for the understanding of the dynamics and structural basis of the GPCRRAMP interactions in a membrane environment. Results indicate that the study of protein-proteininteractions using CG needs further improvement with a more accurate parameterization that will allowthe study of complex systems.
7
Troupiotis-Tsaïlaki, Anastassia. "Lipid-GPCR interactions: from activation of sphingosine-1-phosphate receptors to modulation of vasopressin V2 receptor function." Doctoral thesis, Universite Libre de Bruxelles, 2015. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/216727.
Full textAbstract:
GPCRs form the largest family of membrane proteins in human genome and mediate signal transmission in a wide panel of essential physiological processes, and they are thus a major source of pharmaceutical targets. Investigating GPCR interactions with their cognate ligands and their membrane environment is crucial to understand their function at a molecular level. While major breakthroughs in the determination of high resolution structures of GPCRs in inactive and active states have shed a new light on the structural basis of GPCR activation process, complementary approaches are needed to investigate its dynamic aspects in the context of a native lipid environment. Our research work falls within this scope and hinges on two main issues: on the one hand, understand which structural features of the agonist underlie the activation of S1P receptors; on the other hand determine if membrane lipids modulate the structure and the function of the vasopressin V2 receptor (V2R). First, we investigated the functional response of S1P1, S1P2, S1P4 and S1P5 receptors expressed in mammalian cells to a series of synthetic derivatives of the native ligand sphingosine-1-phosphate, of variable alkyl chain length. Our data demonstrated that the hydrophobic tail of the ligand is crucial to induce activation in S1P receptors family, and revealed subtype-specificities regarding the influence of the alkyl chain length. Our experimental results combined with molecular dynamics simulation lead us to propose an activation mechanism for S1P receptors family. In the second part of our work, we reconstituted purified V2R into systems of controlled lipid composition, mimicking the membrane bilayer. Structural and functional characterization of the receptor in different lipid environments, using infrared and fluorescence spectroscopy approaches, revealed that the lipid composition affects V2R conformation and its interaction with a specific ligand. Taken together, our research work contributes to a better understanding of GPCRs activation mechanism and its regulation by lipid environment.Les récepteurs couplés aux protéines G (GPCRs) forment la plus grande famille de protéines membranaires du génome humain et contribuent à une kyrielle de processus physiologiques essentiels, qui leur confèrent un intérêt pharmacologique majeur. Étudier l'interaction de ces protéines avec leurs ligands et leur environnement membranaire est primordial pour appréhender leur fonctionnement à l’échelle moléculaire. Bien que de remarquables avancées dans la détermination de structures à haute résolution de GPCRs à l'état inactif et actif aient permis de comprendre certaines bases structurales du fonctionnement des récepteurs, des approches complémentaires donnant un aperçu des aspects dynamiques et dans un environnement natif sont nécessaires pour cerner pleinement leur mécanisme d'activation. Notre travail de thèse s'inscrit dans cette problématique et s'articule autour de deux sujets: d'une part, comprendre quelles caractéristiques structurales du ligand sous-tendent l'activation de la famille des récepteurs au sphingosine-1-phosphate (S1P); d'autre part, déterminer si les lipides de la membrane plasmique modulent la structure et la fonction du récepteur à la vasopressine V2. Pour répondre à notre première question, nous avons étudié la réponse fonctionnelle en système cellulaire des récepteurs S1P1, S1P2, S1P4 et S1P5 à des composés synthétiques dérivés du S1P, portant des chaînes alkyles de longueur variable. Nos données mettent en évidence que la longueur de la chaîne hydrocarbonée du ligand est un paramètre crucial dans sa capacité d'induire l'activation du récepteur et ce pour l'ensemble des sous-types étudiés. De plus, nos résultats suggèrent que le comportement vis-à-vis de la longueur de chaîne dépend du sous-type de récepteur considéré. Nos résultats expérimentaux, combinés à une approche de modélisation dynamique, ont abouti à proposer un mécanisme d'activation pour la famille des récepteurs au S1P. Dans le second volet de notre travail, nous avons reconstitué le récepteur V2 purifié dans des systèmes de composition lipidique contrôlée, mimant la bicouche membranaire. Nous avons procédé à la caractérisation structurale et fonctionnelle du récepteur inséré dans différentes types de lipides, par des méthodes spectroscopiques infrarouge et de fluorescence. Les données obtenues suggèrent que la composition lipidique affecte la conformation et la fonction du récepteur. L'ensemble de nos travaux contribue ainsi à une meilleure compréhension du mécanisme d'activation des GPCRs et de leur régulation par l'environnement lipidique.
Doctorat en Sciences
info:eu-repo/semantics/nonPublished
8
Bucco, Olgatina, and olgatina@gmail com. "Preparing, measuring and capturing G-protein coupled receptor (GPCR) signalling complexes for future development of cell-free assay technologies." Flinders University. medicine, 2006. http://catalogue.flinders.edu.au./local/adt/public/adt-SFU20060703.114912.
Full textAbstract:
G-protein coupled receptors (GPCRs) are integral membrane proteins which
represent primary cellular targets for intracellular signalling. Many of these receptors
are altered in disease states and hence are the target for over 50% of marketed drugs.
Despite their physiological importance, high-throughput, cell-free assays which
measure functional or signalling activity are only recently being investigated. The
current approach by the pharmaceutical industry to initially screen compounds for
functionality is to use heterologous cell-based assay formats. The aim of this work
was to reconstitute a cell-free GPCR signalling system on an appropriate platform
(surface) as a prototype for future rapid drug screening and other applications. The
proof-of-concept approach involved using the �2A-adrenergic receptor (�2A-AR)
containing cell membrane preparations as the model GPCR, reconstituted with a set
of heterotrimeric G-proteins; G�i1 and �1�2 (the signal transducing complex being
termed a �transductosome�). However, other receptors and G-proteins were also
investigated. Receptors were initially obtained from natural (tissue) sources, however
in the later stages they were expressed in a heterologous system (insect or
mammalian expression system). G-proteins were expressed in Spodoptera
frugiperida (Sf9) insect cells using the baculovirus expression system. Receptor
expression was verified by radioligand binding assays and endogenous G-proteins
were removed from membrane preparations using the chaotropic agent urea to allow
for reconstitution with purified G-proteins. Signal transduction through the
transductosome was measured using the [35S]GTP�S binding assay. Receptor
activated [35S]GTP�S binding was used to determine functional reconstitution and to
validate that the system was working in the normal physiological manner both on and
off a surface (with surface attachment being via histidine attachment on the G�i1
(6xHIS) subunit). Using the captured (surface-attached) transductosomes, the IC50 values for Rauwolscine, Yohimbine (potent �2-AR antagonists), Prazosin (potent �1-
AR antagonist) and Propranolol (�-AR antagonist) displayed the appropriate rank
order for this class of receptor. This cell-free, surface-attached signalling complex
prototype may have use in the future development of drug screening and discovery
assay technologies as well as other applications as an alternative to cell-based assays
which are not readily amendable to miniaturisation, long term storage and therefore
stable robust microarray formats.
9
Byrne, Eamon. "Molecular mechanisms of Hedgehog signal transduction by the G-protein coupled receptor smoothened." Thesis, University of Oxford, 2017. https://ora.ox.ac.uk/objects/uuid:38abef20-ae98-4835-919c-73afc21a6252.
Full textAbstract:
The Hedgehog signalling pathway is an essential developmental pathway present in all bilaterians that is involved in embryogenesis, body patterning and stem cell homeostasis. Dysregulation of the Hh pathway leads to various kinds of cancer, such as basal cell carcinoma and medulloblastoma. Smoothened (SMO), a Frizzled-type G-protein coupled receptor (GPCR), is the essential transmembrane signal transducer within the Hh pathway, conveying the signal from the upstream transmembrane protein, Patched1 (Ptc1), to the downstream intracellular proteins. The mechanisms by which SMO transmits the Hh signal from the extracellular environment, through the plasma membrane and to the intracellular proteins are not known. In this thesis, I present my work into the structural and functional characterisation of the extracellular and transmembrane domains (TMD) of human SMO in order to better understand the molecular mechanisms of its signal transduction. The extracellular region of SMO contains a highly conserved cysteine-rich domain (CRD) and a linker domain (LD). I present the first crystal structure of the CRD, LD and TMD of SMO, which is also the first crystal structure of a GPCR with a large functional extracellular domain. This structure revealed a domain architecture for SMO that enables regulation of its transmembrane domain by its extracellular domains. It also revealed a cholesterol molecule bound to the CRD, which we subsequently determined to be a new endogenous small-molecule agonist for SMO. I present five further structures of SMO bound to different small molecule agonists and antagonists. Together, these structures demonstrate that the position of the CRD relative to the TMD reflects the activation state of SMO. We also generated nanobodies against the extracellular region of SMO in order to stabilise its conformation. These studies not only improve our understanding of the workings of a key transmembrane protein within a fundamental signalling pathway but will also aid efforts to develop better therapeutics for an important cancer target.
10
Gata, Gabriel. "Regulated export of G-protein coupled receptors." Thesis, Paris 5, 2014. http://www.theses.fr/2014PA05T066.
Full textAbstract:
La plus grande famille de récepteurs membranaires est constituée par des récepteurs à sept domaines transmembranaires couplés aux protéines G (RCPG). Ces récepteurs sont impliqués dans un grand nombre de réponses cellulaires physiologiques et pathologiques et représentent la ciblé de une grande majorité des produits thérapeutiques. La fonction d’un récepteur est déterminée par la quantité de récepteur fonctionnel à la surface cellulaire, qui dépend de différents paramètres comme le niveau de biosynthèse, l’export vers la surface cellulaire à partir de stocks intracellulaires, l’endocytose et les modifications post-transcriptionelles (ex. phosphorylation). Le nouveau concept d’export régulé pour les RCPG présent l’importance physiologique de la rétention de récepteurs, leur relargage, leur interaction avec les partenaires chaperonnes et les escortes. Les études présentées ici concernent les mécanismes d’export régulé de deux RCPG, le récepteur métabotropique de l’acide γ-amino butyrique (GABAB) et le récepteur de chimiokines CC 5 (CCR5). GABAB est un récepteur constitué de deux sous-unités GB1 et GB2 et CCR5 est probablement un homo-dimer. GB1 ainsi que CCR sont retenus dans des compartiments intracellulaire (RE et appareil Golgi) d’où ils sont relâchés en réponse à un signal extern (CCR5) ou/et en interagissant avec protéines d’escorte (comme CD4 pour CCR5 et GB2 pour GB1). L’objectif de ces études était de comprendre le mécanisme de rétention de ces récepteurs et leur régulation. Dans ce contexte, nous avons déterminé en utilisant des approches biophysiques et biochimiques que ces récepteurs interagissent de façon spécifique avec les membres de Prenylated Rab Acceptors Family (PRAF). Ces protéines sont résidentes dans le RE (PRAF2 et PRAF3) et dans le appareil Golgi (PRAF1) où elles fonctionnent comme de gatekeepers pour les récepteurs. Nous avons pu démontrer que PRAF2 interagie de manière spécifique avec des motifs de rétention connus pour leur implication dans la rétention de récepteurs. Cette interaction détermine une rétention au niveau de RE donc régule de façon négatif l’export vers la membrane cellulaire. Dans le cas de récepteur GABAB, l’interaction de GB2 avec GB1 permet la libération de GB1 de sa rétention par PRAF2 par simple compétition. La modification de l’équilibre stoichiométrique entre les gatekeepers PRAF et les protéines d’escorte pour les récepteurs induit des modifications de la fonction du récepteur in vitro et in vivo. Les PRAFs sont ubiquitaires et peuvent interagir avec plusieurs RCPG représentant dans ce cas des régulateurs majors de la fonction de RCPG dans des conditions physiologiques et pathologiquesThe largest family of membrane receptors is constituted by conserved seven-membrane domain spanning receptors, the G-protein coupled receptors (GPCRs). They are involved in numerous cell responses and diseases thus being a major drug target. Receptor function is determined by the amount of active receptors at the cell surface, which depends on various parameters, such as the biosynthetic rate, the export to the cell surface from internal stores, the endocytosis and post-transcriptional modifications (i.e. phosphorylation). Only recently, the importance of the regulated export has emerged, shedding new light on the physiological role of receptor retention, release, chaperoning and escorting. This work concerns the regulated export mechanisms of two members of the GPCRs family, the chemokine receptor 5 (CCR5) and the metabotropic receptor of the g amino butyric acid (GABAB). Whereas CCR5 is likely a homo-dimer of 2 identical protomers, GABAB is an obligatory hetero-dimer of 2 distinct subunit known as GB1 and GB2. Both CCR5 and GB1 are retained in intracellular compartments (the ER and the Golgi) from which they are released in response to external signals (CCR5) and/or interaction with “private escort proteins” (CD4 for CCR5 and GB2 for GB1). The main goal of our work was to understand the mechanism of retention of these receptors and its regulation. In this context, we determined using biochemical and biophysical approaches that these GPCRs specifically interact with the members of the Prenylated Rab Acceptor Family (PRAF). These proteins are resident either in the ER (PRAF2 and PRAF3) or in the Golgi apparatus (PRAF1) where they function as receptor gatekeepers. Indeed, we could document for PRAF2 that this protein likely interacts directly with previously identified receptor retention motifs and inhibits receptor egress from the ER and subsequent trafficking to the plasma membrane. In the context of the GABAB receptor, PRAF2-dependent retention of GB1 can be overridden by GB2 via simple competition. Perturbing the stoichiometry of PRAF gatekeepers respective to that of receptors significantly perturbs receptor function both in vitro and in vivo. Because PRAFs are ubiquitous and seem to interact with many other GPCRs, they might represent major regulators of receptor function both in physiological and pathological conditions
11
Bittencourt, Fabiola M. "Examination of the Function of the Murine Cytomegalovirus Encoded G Protein-Coupled Receptor M33 in vivo." University of Cincinnati / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1397234044.
Full text
12
Sheffler, Douglas James. "The Regulation of G Protein-Coupled Receptor (GPCR) Signal Transduction by p90 Ribosomal S6 Kinase 2 (RSK2)." Connect to text online, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=case1130777469.
Full text
13
Sallander, Eva Jessica. "The mechanism of G protein coupled receptor activation: the serotonin receptors." Doctoral thesis, Universitat Pompeu Fabra, 2011. http://hdl.handle.net/10803/77901.
Full textAbstract:
Una de las principales cuestiones en farmacología molecular de los GPCR es entender los mecanismos estructurales de las siete hélices transmembrana (TM) que se producen para estabilizar ya sea Rg o los diferentes estados R*. Para entender el mecanismo que cambia el equilibrio del conjunto a un estado activo R* se construyeron tres de los receptores de la serotonina (5-HT4, 5-HT6, y 5 HT7) sobre la base de su información más reciente de cristalografía de rayos X. Dando lugar a dos modelos de cada receptor: una inactiva y otra activa. Los modelos, mejorados y evaluados con la ayuda de datos farmacológicos y químicos se utilizaron principalmente para comprender la interacción entre un ligando y su receptor y su mecanismo de acción. Estos hallazgos estructurales pueden a su vez resultar útiles para el diseño de nuevos fármacos más eficaces y selectivos.One of the main questions in G protein coupled receptors (GPCRs) molecular pharmacology is to understand the structural arrangements of the seven transmembrane (TM) helices that occur to stabilize either the ground state (Rg) or different active states (R*) of the receptors. In order to understand the mechanism that shift the equilibrium of the ensemble to an active R* state models of the inactive and the active state of three serotonin receptors (5-HT4, 5-HT6, and 5-HT7) were built based on the latest information from X-ray crystallography. The resulting models were mainly used to understand the interaction between a ligand and its receptor and the mechanism of action. With the help of pharmacological and chemical data these models and complexes were improved and evaluated. These findings may prove valuable for structural based drug discovery efforts and facilitate the design of more effective and selective pharmaceuticals.
14
Gloriam, David E. "G Protein-Coupled Receptors; Discovery of New Human Members and Analyses of the Entire Repertoires in Human, Mouse and Rat." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Universitetsbiblioteket [distributör], 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6745.
Full text
15
Nojima, Shingo. "Cryo-EM Structure of the Prostaglandin E Receptor EP4 Coupled to G Protein." Doctoral thesis, Kyoto University, 2021. http://hdl.handle.net/2433/263574.
Full text
16
Gulati, Sahil Gulati. "Modulating G Protein-Coupled Receptor Signaling Pathways with Selective Chemical- and Protein-Based Effector Molecules." Case Western Reserve University School of Graduate Studies / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=case1530642105672697.
Full text
17
GRILLO, Maria. "IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF GPCR23/LPA4 AS A CANDIDATE G PROTEIN-COUPLED RECEPTOR FOR GUANOSINE." Doctoral thesis, Università degli Studi di Palermo, 2014. http://hdl.handle.net/10447/90984.
Full textAbstract:
La guanosina esercita diverse funzioni a livello del Sistema Nervoso Centrale, coinvolgendo recettori di membrana accoppiati a proteine G (GPCR) non ancora identificati. Pertanto, l’obiettivo della ricerca è stato quello di individuare e caratterizzare uno specifico recettore funzionale per la Guanosina. I dati ottenuti su linee cellulari hanno dimostrato che il legame della guanosina con le membrane plasmatiche è incrementato dall’over-espressione del GPCR23 e ridotto dal suo silenziamento ed hanno evidenziato l’attivazione di un GPCR in risposta alla guanosina. A livello cerebrale il GPCR23 è risultato essere maggiormente espresso nella regione corticale, dove si è dimostrata anche una notevole interazione funzionale della guanosina con le membrane cellulari rispetto ad altre strutture cerebrali. Presi nel loro complesso questi dati suggeriscono che il GPCR23 possa agire come recettore funzionale di membrana responsivo alla guanosina.Several studies have shown that guanine-based purines exert biological effects on the central nervous system (CNS), possibly through membrane receptors, but at the present there are not reports related to the identification of such specific receptor(s). According to the results shown in this thesis, we have identified the first guanosine G protein-coupled receptor GPCR23, also known as LPA4 receptor. [3H]-Guanosine radioligand binding assay reveals that [3H]-Guanosine binding to membrane fractions is greatly enhanced by GPCR23 overexpression and reduced by GPCR23 silencing. Furthermore, in [35S] GTPγS binding assay experiments, Guanosine causes a functional G-protein coupled receptor activation in U87-GPCR23 overexpressing cells with an EC50= 8,067 nM. The binding site for [3H]-guanosine is highly specific as well as both lysophosphatidic acid (LPA) and guanine agonists are 10 times less effective than guanosine in displacing 50 nM [3H]-guanosine binding. In order to correlate the effects of guanosine in the CNS to a putative interaction with specific binding sites and in particular to GPCR activation, we performed, in different brain areas [3H]-Guanosine radioligand binding assay and [35S]-GTPγS binding assay. Among the examined brain tissues, the cerebral cortex showed the highest maximal number of binding sites for Guanosine as compared to other brain regions. In each tested brain area, the saturation curves indicates the presence of a single high affinity binding site since it is resolved by non-linear regression analysis with a one-site model. In cortical membranes KD value is 143,8 nM and Bmax 3713 fmol/mg protein. The other considered areas show lower Bmax values for [3H]-Guanosine, with the following rank order: cerebral cortex>hippocampus>striatum>spinal cord. The existence of a specific receptor coupled to a G protein for guanosine in cortical membranes, thus compatible with GPCR23, is also validated by [35S] GTPγS binding assay experiments that demonstrate the activation of a G protein-coupled receptor in response to guanosine both in autoradiography sagittal sections and in cerebral cortex membranes. With the purpose of evaluate downstream signaling activated by guanosine interaction with its binding sites; we conducted in vivo and in vitro experiments. According to our Dott.ssa Maria Grillo Pagina 4 results, Guanosine effects in cerebral cortex may be mediated by ERK1/2 and/or PLC pathways activation. In particular, i.p. administration of 7,5 mg/kg in rats induced ERK enhanced phosphorylation in cortical tissue, with a peak effect at 30 minutes after injection . On the other hand, treatment of cortical neurons with guanosine causes at 7,5 minutes both PLCγ and ERK1/2 pathways activation. Taken together, our findings demonstrate that GPCR23 is the first Receptor for Guanosine and suggest an involvement of GPCR23 in the functional response of cerebral cortex to Guanosine. Even if these observations do not exclude a possible involvement of other unidentified receptors, our study lays the foundation for identification of receptors responsive to Guanine-based purines (GBPs), both in nervous system and in other peripheral tissues and may provide new targets for neuroprotection and neuromodulation.
18
Sreedharan, Smitha. "Functional Characterization of Centrally Expressed Solute Carriers and G Protein-Coupled Receptors." Doctoral thesis, Uppsala universitet, Funktionell farmakologi, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-156832.
Full textAbstract:
Transmembrane proteins are gatekeepers of the cells; controlling the transport of substrates as well as communicating signals among cells and between the organelles and cytosol. Solute carriers (SLC) and G protein-coupled receptors (GPCR) are the largest family of membrane transporters and membrane receptors respectively. The overall aim of this thesis was to provide a basic understanding of some of the novel SLCs and GPCRs with emphasis on expression, transport property, evolution and probable function. The first part of the thesis directs towards the study of some novel solute carriers. In an initial study, we provided an overall picture of the sequence relationship and tissue expression of 14 diverse atypical SLCs confirming some of their evolutionary conservation and highly specific expression pattern. The focus then was on the SLC17 family (mainly vesicular proteins) and a novel member named Slc17a9. This study revealed that SLC17 family could be divided into four main phylogenetic clades which were all present before the divergence of the insect lineage with Slc17a9 having the most restricted evolutionary history. Detailed expression study of Slc17a9 in the mouse brain suggests that it is also expressed in some regions important for purinergic neurotransmission. Further, we deorphanised an aminoacid transporter Slc38a7 which was expressed in a majority of neurons in the CNS and showed that it preferably mediate transport of L–glutamine and L–histidine. The second part of the thesis focuses on the study of two GPCRs belonging to the Rhodopsin superfamily, Gpr162 and Gpr153. A phylogenetic analysis revealed that both Gpr153 and Gpr162 originated from a common ancestor before the radiation of the mammalian lineage. Expression study revealed that Gpr162 had a predominant expression in the CNS and relatively lower expression in the other tissue tested whereas Gpr153 had a more widespread and similar expression pattern in both CNS and peripheral tissues. The functional studies of the two GPCRs were done using the antisense oligodeoxynucleotide knockdown rat model. These studies provided evidence linking the orphan Gpr162 gene with the regulation of food intake– related behaviour whereas Gpr153 gene caused only a slight reduction in food intake.
19
Maxwell, Stropes Melissa Page. "Signaling and Regulation of the Human Cytomegalovirus G-Protein Coupled Receptor US28 in HCMV Infected Cells." University of Cincinnati / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1236016578.
Full text
20
Gaudio, Sabrina. "Functional characterization of the interaction between G protein coupled receptors (GPCR) and regulators of G protein signaling (RGS) in yeast." Thesis, McGill University, 2005. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=97959.
Full textAbstract:
Regulators of G-protein Signaling (RGSs) are proteins which attenuate G-Protein coupled receptor (GPCR) signaling by acting as GAPs (GTPase activating proteins) for the Galpha subunit of the heterotrimeric G protein. Although RGSs have been clearly shown to bind the Galpha subunit of heterotrimeric G-proteins, recent studies have shown that RGS specificity occurs via receptor association. To examine possible RGS/GPCR interactions, we constructed a somatostatin 5 (SST5) receptor deletion mutant lacking most of its intracellular C-tail. Here we show that the activation of a GPCR-responsive FUS1 -LacZ reporter gene in yeast strains expressing full length WT SST5 receptor as well as the C-terminally truncated mutant were both inhibited by RGSs 1, 2, 5 and 16, suggesting that the C-tail does not play an integral role in RGS function. As an alternative approach to examine possible RGS/GPCR interactions, RGS function was analyzed via halo assay in yeast cells expressing different RGSs as well the C-tail of different GPCRs including mouse LPA 1, LPA4, Cbeta1, 5HT2A, beta 2AR and human SST5 receptors as well as the third intracellular loop of human SST5. The C-tails and the i3-loop were constructed as GFP fusions. Western blot analysis confirmed that the fusions were expressed in yeast. Of all the combinations of GPCR-C-tail-GFP fusions and RGSs expressed in yeast, only LPA4-GFP was able to interfere with RGS2 function. RGS function was also not inhibited by the expression of SST5-i3-GFP. This suggests that there is a high degree of specificity involved in dictating the interaction between RGSs and GPCRs. In a second study, we wanted to further characterize an immunoreactive RGS5 protein band which was detected from western blot analysis of extract from a yeast strain expressing RGS5 and that was double the size of RGS5. To examine the possibility that this band represents an RGS5 dimer, we examined the molecular weight of RGS5 protein in yeast cells expressing an RGS5-GFP fusion. Western blot analysis of yeast extract expressing GFP-tagged RGS5 detected a band at approximately 50 kDa (representing RGS5-GFP) and a second band at 100 kDa. This suggests that RGS5, like GPCRs, are capable of forming dimers.
21
Fischer, Liane, Caroline Wilde, Torsten Schöneberg, and Ines Liebscher. "Functional relevance of naturally occurring mutations in adhesion G protein-coupled receptor ADGRD1 (GPR133)." Universitätsbibliothek Leipzig, 2016. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-208803.
Full textAbstract:
Background: A large number of human inherited and acquired diseases and phenotypes are caused by mutations in G protein-coupled receptors (GPCR). Genome-wide association studies (GWAS) have shown that variations in the ADGRD1 (GPR133) locus are linked with differences in metabolism, human height and heart frequency. ADGRD1 is a Gs protein-coupled receptor belonging to the class of adhesion GPCRs. Results: Analysis of more than 1000 sequenced human genomes revealed approximately 9000 single nucleotide polymorphisms (SNPs) in the human ADGRD1 as listed in public data bases. Approximately 2.4 % of these SNPs are located in exons resulting in 129 non-synonymous SNPs (nsSNPs) at 119 positions of ADGRD1. However, the functional relevance of those variants is unknown. In-depth characterization of these amino acid changes revealed several nsSNPs (A448D, Q600stop, C632fs [frame shift], A761E, N795K) causing full or partial loss of receptor function, while one nsSNP (F383S) significantly increased basal activity of ADGRD1. Conclusion: Our results show that a broad spectrum of functionally relevant ADGRD1 variants is present in the human population which may cause clinically relevant phenotypes, while being compatible with life when heterozygous.
22
Bjarnadóttir, Þóra Kristín. "The Gene Repertoire of G protein-coupled Receptors : New Genes, Phylogeny, and Evolution." Doctoral thesis, Uppsala University, Department of Neuroscience, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6627.
Full textAbstract:
The superfamily of G protein-coupled receptors (GPCRs) is one of the largest protein families of mammalian genomes and can be divided into five main families; Glutamate, Rhodopsin, Adhesion, Frizzled, and Secretin. GPCRs participate in most major physiological functions, contributing to the fact that they are important targets in drug discovery. In paper I we mined the human and mouse genomes for new Adhesion GPCR genes. We found two new human genes (GPR133 and GPR144) and 17 mouse Adhesion genes, bringing the number up to 33 human and 31 mouse genes. In paper II we describe 53 new splice variants for human Adhesion receptors supported by expressed sequence tags (EST) data. 29 of these variants seem to code for functional proteins, several of which lack one or more functional domains in the N-termini. Lack of certain domains is likely to affect ligand binding or interaction with other proteins. Paper III describes the Glutamate GPCR in human, mouse, Fugu, and zebrafish. We gathered a total of 22 human, 79 mouse, 30 Fugu, and 32 zebrafish sequences and grouped these into eight clans using phylogenetic methods. The report provides an overview of the expansion or deletions among the different branches of the Glutamate receptor family. Paper IV focuses on the trace amine (TA) clan of Rhodopsin GPCRs. We identified 18 new rodent genes, 57 zebrafish genes, and eight Fugu genes belonging to the clan. Chromosomal mapping together with phylogenetic relationships suggests that the family arose through several mechanisms involving tetraploidisation, block duplications, and local duplication events. Paper V provides a comprehensive dataset of the GPCR superfamily of human and mouse containing 495 mouse and 400 human non-olfactory GPCRs. Phylogenetic analyses showed that 329 of the receptors are found in one-to-one orthologous pairs, whereas other receptors may have originated from species-specific expansions.
23
Meoli, Luca. "Comprehensive phenotyping of two mouse mutants reveals a potential novel role of G protein-coupled receptor 30." Doctoral thesis, Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2011. http://dx.doi.org/10.18452/16263.
Full textAbstract:
Publikationen die in letzter Zeit veröffentlicht wurden zeigten den G Protein-gekoppelte Rezeptor 30 (Gpr30) als neuer potenzieller Östrogen Rezeptor. Dieser Befund wird kontrovers diskutiert, zudem wurde die physiologische Funktion von Gpr30 bisher noch nicht vollständig geklärt. Ziel der vorliegenden Arbeit war die Erforschung der Rolle von Gpr30 in vivo. In einer primären und sekundären Untersuchung wurde eine phänotypische Charakterisierung einer Gpr30-defizienten Mauslinie vorgenommen. Diese Mauslinie wurde generiert, indem eine beta-Galactosidase-Neomycin Vektorkassette in den open reading frame des Gpr30 Gens eingesetzt wurde. Im Rahmen der primären Untersuchung zeigte die immunologische Analyse eine Reduzierung der T-Zellen sowohl bei den männlichen als auch bei den weiblichen mutanten Mäusen. In einer Thymus-Genexpressionanalyse konnten einige Gene identifiziert werden, die möglicherweise in der Regulation der Anzahl an T-Zellen involviert waren. Auf der Grundlage dieser Ergebnisse wurde eine Erhöhung der Kalzium-vermittelten T-Zellen Apoptose hypothetisiert. Gegenstand der sekundären Untersuchung war die Bestimmung eines möglichen metabolischen und kardiovaskulären Phänotyps, da Gpr30 überwiegend in den Blutgefäßen verschiedener Organe, sowie in der Pankreas und im Magen exprimiert ist. Zu diesem Zweck wurden die Mäuse einer Hochfettdiät unterzogen und es wurden metabolische sowie hemodynamische Tests durchgeführt. Um den Phänotyp dieser ersten Mauslinie zu bestätigen, wurde eine zweite Mauslinie ohne Selektionsmarker generiert. Insgesamt tragen die Ergebnisse der vorliegenden Studie zu einem besseren Verständnis der Funktion von Gpr30 in vivo bei. Eine Rolle des Rezeptors bezüglich der Regulation des Körpergewichts konnte widerlegt werden, während ein Einfluss auf den Lipid- und Muskelstoffwechsel angenommen werden kann. Zudem wurde gefunden, dass Gpr30 für einige Östrogen-regulierende, physiologische Prozesse nicht erforderlich ist.Recent studies identified the G protein-coupled receptor 30 (Gpr30) as a potential new estrogen receptor. However, these findings remain still controversial and the physiological role of Gpr30 has not been clarified yet. In order to decipher the role of Gpr30 in vivo, we investigated the phenotype of a Gpr30 mutant mouse line, generated by the insertion of a beta-galactosidase-neomycin cassette into the Gpr30 open reading frame, in a primary and a secondary screen. The primary screen revealed a decrease of T cell levels in both male and female mutants. Thymus gene expression analysis allowed to detect some of the genes potentially involved in regulating T cell levels in these mice. On this basis a hypothesis of an increase in T cell calcium-mediated apoptosis was formulated. The secondary screen aimed at unraveling a potential metabolic and cardiovascular phenotype, being Gpr30 mainly expressed in the vasculature of several organs, as well as in the pancreas and in the chief gastric cells of the stomach. Therefore, mice were challenged with a defined high fat diet, and metabolic and hemodynamic tests were performed. To confirm the phenotype achieved in this first mouse line, a second one, devoid of any selection marker, was analyzed. Altogether the results achieved may contribute to a better understanding of Gpr30 function in vivo, disproving a role of Gpr30 in body weight regulation, suggesting a role in lipid and muscular metabolism, and providing evidence that Gpr30 may not be required for several estrogen-regulated physiological processes.
24
Morizzo, Erika. "G Protein-Coupled Receptors as Potential Drug Target: From Receptor Topology to Rational Drug Design, an in-silico Approach." Doctoral thesis, Università degli studi di Padova, 2009. http://hdl.handle.net/11577/3426081.
Full textAbstract:
G protein-coupled receptors (GPCRs) constitute a very large family of heptahelical, integral membrane proteins that mediate a wide variety of physiological processes, ranging from the transmission of the light and odorant signals to the mediation of neurotransmission and hormonal actions. GPCRs are dysfunctional or deregulated in several human diseases and are estimated to be the target of more than 40% of drugs used in clinical medicine today.
The crystal structures of rhodopsin and the recent published crystal structures of beta-adrenergic receptors and human A2A Adrenergic Receptor provide the information of the three-dimensional structure of GPCRs, which supports homology modeling studies and structure-based drug-design approaches. Rhodopsin-based homology modeling has represented for many years a widely used approach to built GPCR three-dimensional models. Structural models can be used to describe the interatomic interactions between ligand and receptor and how the binding information is transmitted through the receptor.
Both agonist and antagonist like states can be described by several different conformational receptor states depending on the nature of both ligand and receptor. Considering different complementarities, we might explore different conformations of the same pharmacological state.
We investigated the molecular pharmacology of adenosine receptors and, in particular, the human A3 adenosine receptor (hA3AR) by using an interdisciplinary approach to speed up the discovery and structural refinement of new potent and selective hA3AR antagonists. Human A3AR belongs to adenosine receptors family of GPCRs, which consists of four distinct subtypes: A1, A2A, A2B, A3 that are ubiquitously expressed in the human body.
The hA3AR, which is the most recently identified adenosine receptor, is implicated in a variety of important physiological processes. Activation of A3ARs increases the release of inflammatory mediators, such as histamine from rodent mast cells, and it inhibits the production of tumor necrosis factor-alpha. The activation of the hA3AR seems to be involved in immunosuppression and in the response to ischemia of the brain and heart. Agonists or antagonists of A3ARs are potential therapeutic agents for the treatment of ischemic and inflammatory diseases.
The first model of human A3AR has been built using a conventional rhodopsin-based homology modeling approach. The model has been used to probe atomic level specific interactions, detected using site-directed mutagenesis analysis.
The rhodopsin-based model of the hA3AR in its resting state (antagonist-like state) has been revisited, taking into account a novel strategy to simulate the possible receptor reorganization induce by the antagonist-binding. We called this new strategy ligand-based homology modeling (LBHM). It is an evolution of a conventional homology modeling algorithm: any selected atoms will be included in energy tests and in minimization stages of the modeling procedure. Ligand-based option is very useful when one wishes to build a homology model in the presence of a ligand docked to the primary template. Starting from the conventional rhodopsin-based homology model and applying our ligand-based homology modeling implementation we can generate other antagonist-like conformational states of hA3AR in which the ligand recognition cavity is expanded. Using different antagonist-like conformational states, we are able to rationalize the observed activities for all the compounds analyzed. Many severe analysis concerning false-positives and false-negatives situations are usually conducted.
To strictly validate this methodology as novel tool to address the multi-conformational space of GPCRs, we have analyzed different classes of known human A3 antagonists in the corresponding putative ligand binding site: for example triazoloquinoxalin-1-one derivatives, arylpyrazolo-quinoline derivatives and pyrazolo-triazolo-pyrimidines derivatives. These studies led to the identification of groups for every class of antagonists that, introduced one by one in a suitable position, afford high hA3AR affinity and good selectivity.
Starting from these binding requirements, we decided to perform an in silico molecular simplification approach to identify a suitable fragmentation route of the 4-amino-triazoloquinoxalin-1-one scaffold and explore which of the structural features were essential to guarantee efficient ligand-receptor recognition.
With the availability of new three dimensional templates different from rhodopsin, we built new models of hA3AR. All the models were used for a molecular dynamic simulation in a POPC bilayer to investigate the topological fluctuation of the binding pocket.I recettori accoppiati alle proteine G (GPCR) costituiscono una grande famiglia di proteine integrali di membrana caratterizzate da sette eliche transmenmbrana, che mediano un'ampia gamma di processi fisiologici che vanno dalla trasmissione della luce e dei segnali olfattivi alla mediazione della neurotrasmissione e dell'azione degli ormoni. I GPCR mancano di una corretta regolazione in molte patologie umane ed è stato stimato che costituiscano il target del 40% dei medicinali utilizzati attualmente in clinica. La struttura cristallografica della rodopsina e le strutture più recenti del recettore beta adrenergico e del recettore adenosinico A2A forniscono l'informazione strutturale che sta alla base della costruzione di modelli per omologia e degli approcci di structure-based drug design dei GPCR. La costruzione di modelli di GPCR per omologia basati sulla struttura della rodopsina ha rappresentato per molti anni un approccio ampiamente utilizzato. Questi modelli possono essere usati per descrivere le interazioni interatomiche tra ligando e recettore e come le informazioni sono trasmesse attraverso il recettore. Diversi stati conformazionali del recettore possono essere in grado di descrivere la conformazione del recettore che lega l'agonista e quella che lega l'antagonista, a seconda della natura di ligando e recettore. Se si considerano diverse complementarietà, si possono esplorare diversi stati conformazionali di uno stesso stato farmacologico. Noi abbiamo studiato la farmacologia molecolare dei recettori adenosinici e, in particolare, del recettore adenosinico A3 umano (hA3AR), utilizzando un approccio interdisciplinare al fine di massimizzare la scoperta e l'ottimizzazione strutturale di nuovi antagonisti potenti e selettivi per il hA3AR. Il hA3AR fa parte della famiglia dei recettori adenosinici che consiste in quattro diversi sottotipi (A1, A2A, A2B, A3) che sono espressi in tutto il corpo umano. Il recettore adenosinico A3 è stato identificato più recentemente ed è implicato in importanti processi fisologici. L'attivazione del hA3AR aumenta il rilascio di mediatori dell'infiammazione, come l'istamina dalle mastcellule, e inibisce la produzione del TNF-alpha. L'attivazione del hA3AR sembra essere coinvolta nell'immunosoppressione e nella risposta ischemica di cuore e cervello. Agonisti o antagonisti del hA3AR sono potenziali agenti terapeutici nel trattamento di patologie ischemiche e infiammatorie. Il primo modello di hA3AR è stato costruito usando un approccio convenzionale di homology modeling basato sulla rodopsina ed è nel suo stato che lega l'antagonista. Dopo essere stato utilizzato per verificare le interazioni a livello molecolare che erano state evidenziate da studi di mutagenesi, il modello è stato rivisto prendendo in considerazione una nuova strategia che simula la possibile riorganizzazione del recettore indotta dal legame con l'antagonista. Abbiamo chiamato questa strategia ligand-based homology modeling. E' un'evoluzione dell'algoritmo convenzionale di homology modeling: ogni atomo selezionato viente preso in considerazione nei test energetici e nelle fasi di minimizzazione della procedura di modeling. L'opzione ligand-based è molto utile quando si vuole costruire un modello per omologia in presenza di un ligando nella sua ipotetica conformazione di legame nel templato iniziale. A partire dal modello ottenuto dalla rodopsina e applicando la tecnica del LBHM, possiamo generare altri stati conformazionali del recettore hA3AR che legano l'antagonista, nei quali la cavità di riconoscimento del ligando è espansa. Usando diversi stati conformazionali che legano l'antagonista, possiamo razionalizzare l'attività misurata sperimentalmente di tutti i composti analizzati. Sono condotte severe analisi relative a falsi positivi e falsi negativi. Per validare la metodologia come nuovo strumento per indirizzare lo spazio multiconformazionale dei GPCR, abbiamo analizzato diverse classi di antagonisti con attività nota sul hA3AR: ad esempio derivati triazolo-chinossalinonici, derivati arilpirazolo-chinolinici e derivati pirazolo-triazolo-pirimidinici. Questi studi hanno portato all'identificazione di gruppi per ogni classe di antagonisti che, se introdotti in una precisa posizione, portano ad un'alta affinità e ad una buona selettività per il hA3AR. A partire dalle caratteristiche risultate importanti per il legame, abbiamo applicato una tecnica di semplificazione molecolare in silico per identificare una possibile via di frammentazione della struttura 4-amino-triazolochinoassalin-1-onica ed esplorare quali sono le caratteristiche strutturali essenziali per garantire un'efficiente riconoscimento ligando-recettore. Con la disponibilità di nuove strutture tridimensionali da utilizzare come templati diversi dalla rodopsina, abbiamo costruito nuovi modelli del recettore hA3AR. Tutti i modelli sono stati usati per una simulazione di dinamica molecolare in un doppio strato fosfolipidico, per analizzare le fluttuazioni topologiche della tasca di legame.
25
Diness, Frederik. "Solid-phase reactions of N-carbamyliminium ions : from amino aldehydes to on-bead GPCR-screening /." Cph. ; Valby : Department of Medicinal Chemistry, The Danish University of Pharmaceutical Sciences : Center for solid-phase organic combinatiorial chemistry, Carlsberg Laboratory, 2006. http://www.dfuni.dk/index.php/Frederik-Diness/3031/0/.
Full text
26
Ritscher, Lars. "Die Agonistspezifität des G-Protein-gekoppelten Rezeptors GPR34." Doctoral thesis, Universitätsbibliothek Leipzig, 2012. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-97551.
Full textAbstract:
In der vorliegenden Arbeit wurden die molekularen Grundlagen für die Agonistspezifität des G-Protein-gekoppelten Rezeptors GPR34 untersucht. Mittels verschiedener funktioneller Versuche konnte an ausgewählten Orthologen des Rezeptors gezeigt werden, dass, im Gegensatz zu publizierten Daten, Lysophosphatidylserin (Lyso-PS) nicht der natürliche Agonist des GPR34 ist. Lediglich an einigen cyprinoiden Subtypen des GPR34 hat Lyso-PS surrogat-agonistische Effekte. Anhand eines detaillierten evolutionären Vergleichs von Orthologen konnten Bereiche des Rezeptors ermittelt werden, welche an der Ligandenbindung, und damit an der Agonistspezifität des GPR34 beteiligt sind. Durch Übertragung dieser Bereiche vom Karpfen-GPR34-Subtyp 2a auf den humanen GPR34 konnte dieser zu einem Lyso-PS-sensitiven Rezeptor modelliert werden. Weiterhin wurde Aminoethyl-Carbamoyl-ATP (EDA-ATP) als inverser Agonist an cyprinoiden Orthologen des GPR34 identifiziert. Die Erweiterung des möglichen Ligandenspektrums von Lipiden zu Nukleotidderivaten gibt Hinweise auf die Promiskuität der Bindungsstelle des GPR34. Die Ergebnisse zeigen, dass Lyso-PS nur eine zufällige Aktivität an einigen Orthologen des GPR34 hat. Mit Identifizierung eines Nichtlipides als invers-agonistischen Liganden ist die Suche nach dem natürlichen Liganden des GPR34 noch nicht abgeschlossen und sollte auf weitere chemische Entitäten ausgeweitet werdenLyso-PS (lyso-phosphatidylserine) has been shown to activate the G(i/o)-protein-coupled receptor GPR34. Since in vitro and in vivo studies provided controversial results in assigning lyso-PS as the endogenous agonist for GPR34, we investigated the evolutionary conservation of agonist specificity in more detail. Except for some fish GPR34 subtypes, lyso-PS has no or very weak agonistic activity at most vertebrate GPR34 orthologues investigated. Using chimaeras we identified single positions in the second extracellular loop and the transmembrane helix 5 of carp subtype 2a that, if transferred to the human orthologue, enabled lyso-PS to activate the human GPR34. Significant improvement of agonist efficacy by changing only a few positions strongly argues against the hypothesis that nature optimized GPR34 as the receptor for lyso-PS. Phylogenetic analysis revealed several positions in some fish GPR34 orthologues which are under positive selection. These structural changes may indicate functional specification of these orthologues which can explain the species- and subtype-specific pharmacology of lyso-PS. Furthermore, we identified aminoethyl-carbamoyl ATP as an antagonist of carp GPR34, indicating ligand promiscuity with non-lipid compounds. The results of the present study suggest that lyso-PS has only a random agonistic activity at some GPR34 orthologues and the search for the endogenous agonist should consider additional chemical entities
27
Ahmed, Mohaned S. A. "New C-C chemokine receptor type 7 antagonists." Thesis, University of Bradford, 2016. http://hdl.handle.net/10454/14623.
Full textAbstract:
Chemokines are chemotactic cytokines which play an important role in the migration of immune cells to distant tissues or compartments within tissues. These proteins have also been demonstrated to play a major role in cancer metastasis. The C-C chemokine receptor type 7 (CCR7) is a member of the chemokine receptor family. CCR7 along with its ligands CCL19 and CCL21 plays an important role in innate immune response by trafficking of lymphocytes. In cancer, tumour cells expressing CCR7 migrate to lymphoid organs and thus disseminate to other organs. Neutralizing the interactions between CCL21/CCR7 would therefore be expected to inhibit the progression and metastasis of many different types of cancer to regional lymph nodes or distant organs. Our objective was to identify a potent small molecule antagonist of CCR7 as a prelude to the investigation of the role of this axis in cancer metastasis. In this study, we provided a brief description of chemokines and their role in health and disease with an emphasis on the CCR7/CCL19/CCL21 axis, as well as identification of a CCR7 antagonist “hit”. The potency of the CCR7 antagonist “hit” was optimised by synthesizing different CCR7 antagonist analogues. The “hit” optimization process has led to discover the most active compound amongst a series of different analogues which have the ability to bind and block CCR7 receptor. The efficacy of the most active compound and other analogues were evaluated in vitro using a calcium flux assay which is based on detecting fluorescent light emitted upon release of calcium ions. To identify a suitable cell line, which expresses CCR7 and capably respond to it, amongst a panel of cell lines for in vitro assessment of potency of synthesised compounds, we used Western blot assay and later by flow cytometry assay. The activity and selectivity of the most effective compound against CCR7 receptor was evaluated in vitro by other functional assays such as “configured agarose spot assay” and scratch assay. We first configured the existing under agarose assay to fulfil our requirements and then used it to assess activity and selectivity of compounds. The configured agarose spot assay also describes the application of the agarose spot for evaluation of cells chemotactic response to multiple chemokines under identical experiment conditions.
28
Cordomí, Montoya Arnau. "Molecular dynamics simulations of seven-transmembrane receptors." Doctoral thesis, Universitat Politècnica de Catalunya, 2008. http://hdl.handle.net/10803/6464.
Full textAbstract:
Seven transmembrane (7-TM) G protein coupled receptors (GPCR) constitute the largest family of integral membrane proteins in eukaryotes with more than 1000 members and encoding more than 2% of the human genome. These proteins play a key role in the transmission and transduction of cellular signals responding to hormones, neurotransmitters, light and other agonists, regulating basic biological processes. Their natural abundance together with their localization in the cell membrane makes them suitable targets for therapeutic intervention. Consequently, GPCR are proteins with enormous pharmacologic interest, representing the targets of about 50% of the currently marketed drugs. The current limitations in the experimental techniques necessary for microscopic studies of the membrane as well as membrane proteins emerged the use of computational methods and specifically molecular dynamics simulations. The lead motif of this thesis is the study of GPCR by means of this technique, with the ultimate goal of developing a methodology that can be generalized to the study of most 7-TM as well as other membrane proteins. Since the bovine rhodopsin was the only protein of the GPCR family with a known threedimensional structure at an atomic level until very recently, most of the effort is centered in the study of this receptor as a model of GPCR.
The scope of this thesis is twofold. On the one hand it addresses the study of the simulation conditions, including the procedure as well as the sampling box to get optimal results, and on the other, the biological implications of the structural and dynamical behavior observed in the simulations. Specifically, regarding the methodological aspects of the work, the bovine rhodopsin has been studied using different treatments of long-range electrostatic interactions and sampling conditions, as well as the effect of sampling the protein embedded in different one-component lipid bilayers. The binding of ions to lipid bilayers in the absence of the protein has also been investigated.
Regarding the biological consequences of the analysis of the MD trajectories, it has been carefully addressed the binding site of retinal and its implications in the process of isomerization after photon uptake, the alteration a group of residues constituting the so-called electrostatic lock between helices TM3 and TM6 in rhodopsin putatively used as common activation mechanism of GPCR, and the structural effects caused by the dimerization based on a recent semi-empirical model. Finally, the specific binding of ions to bacteriorhodopsin has also been studied.
The main conclusion of this thesis is provide support to molecular dynamics as technique capable to provide structural and dynamical informational about membranes and membrane proteins, not currently accessible from experimental methods). Moreover, the use of an explicit lipidic environment is crucial for the study the membrane protein dynamics as well as for the protein-protein and lipidprotein interactions.
29
Nordström, Karl J. V. "Characterization and Evolution of Transmembrane Proteins with Focus on G-protein coupled receptors in Pre-vertebrate Species." Doctoral thesis, Uppsala universitet, Funktionell farmakologi, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-121696.
Full textAbstract:
G protein-coupled receptors (GPCRs) are one of the largest protein families in mammals. GPCRs are instrumental for hormonal and neurotransmitter signalling and are important in all major physiological systems of the body. Paper I describes the repertoire of GPCRs in Branchiostoma floridae, which is one of the species most closely related species to vertebrates. Mining and phylogenetic analysis of the amphioxus genome showed the presence of at least 664 distinct GPCRs distributed among all the main families of GPCRs; Glutamate (18), Rhodopsin (570), Adhesion (37), Frizzled (6) and Secretin (16). Paper II contains studies of the Adhesion, Methuselah and Secretin GPCR families in nine genomes. The Adhesion GPCRs are the most complex gene family among GPCRs with large genomic size, multiple introns and a fascinating flora of functional domains. Phylogenetic analysis showed Adhesion group V (that contains GPR133 and GPR144) to be the closest relative to the Secretin family among the groups in the Adhesion family, which was also supported by splice site setup and conserved motifs. Paper III examines the repertoire of human transmembrane proteins. These form key nodes in mediating the cell’s interaction with the surroundings, which is one of the main reasons why the majority of drug targets are membrane proteins. We identified 6,718 human membrane proteins and classified the majority of them into 234 families of which 151 belong to the three major functional groups; Receptors (63 groups, 1,352 members), Transporters (89 groups, 817 members) or Enzymes (7 groups, 533 members). In addition, 74 Miscellaneous groups were shown to include 697 members. Paper IV clarifies the hierarchy of the main families and evolutionary origin of majority of the metazoan GPCR families. Overall, it suggests common decent of at least 97% of the GPCRs sequences found in humans, including all the main families.
30
Thomas, Jennifer Ann. "Engineering the angiotensin II type 1 receptor for structural studies." Thesis, University of Cambridge, 2015. https://www.repository.cam.ac.uk/handle/1810/247919.
Full textAbstract:
G protein-coupled receptors (GPCRs) are eukaryotic integral membrane proteins that perform transmembrane signal transduction. Due to their pivotal role in a wide range of essential physiological functions GPCRs represent a high proportion of all drug targets. High resolution X-ray structures of GPCRs are however underrepresented in the Protein Data Bank. This is due to their instability in detergent, low expression levels and the presence of misfolded receptors in many heterologous expression systems. The objective of this project was to engineer the angiotensin II type 1 receptor (AT1R), a human GPCR, to make it suitable for structural studies. It was determined that detergentsolubilised AT1R was thermostable with antagonist bound with an apparent Tm of ~45°C, which was sufficiently stable for purification without further thermostabilisation by rational mutagenesis. Two expression systems were then evaluated for large-scale production of AT1R, namely baculovirus-mediated expression in insect cells and mammalian expression in HEK293 cells. Radioligand binding assays showed that only the mammalian system produced sufficient quantities of active AT1R for structural studies. Expression in the mammalian system was further optimised to approximately 6 mg/L. An AT1R-GFP fusion was created to examine membrane localisation using confocal laser scanning microscopy, to assay expression levels, to select highly expressing monoclonal cell lines using fluorescence activated flow cytometry and to develop a fluorescence size-exclusion chromatographybased assay to examine the suitability of 12 different ligands for co-crystallization. AT1R was also engineered to facilitate crystallisation, including C-terminal truncations to remove predicted disordered regions and bacteriophage T4-lysozyme being added to the third intracellular loop to provide additional points of contact for crystallisation, which increased the apparent Tm by approximately 10°C. All modified versions of AT1R were assessed for expression, stability and monodispersity. Additionally a rapid western blotting based assay was developed for the detection of unfolded membrane proteins, which will have wide applicability in the field.
31
Zaidi, Saheem. "Understanding ligand binding, selectivity and functions on the G protein-coupled receptors: A molecular modeling approach." VCU Scholars Compass, 2014. http://scholarscompass.vcu.edu/etd/596.
Full textAbstract:
The assessment of target protein molecular structure provides a distinct advantage in the rational drug design process. The increasing number of available G protein-coupled receptor crystal structures has enabled utilization of a varied number of computational approaches for understanding the ligand-receptor interactions, ligand selectivity and even receptor response upon ligand binding. The following dissertation examines the results from three different projects with varied objectives – i) structural modeling of human C-C chemokine receptor type 5 (CCR5) and assessment of the ligand binding pocket of the receptor, ii) assessment of the selectivity profile of naltrexone derivatives on the three opioid receptors (μ-opioid, κ-opioid, δ-opioid) with an aim towards designing selective μ-opioid receptor antagonists, and iii) structural modeling of the ‘active’ state conformation of the κ-opioid receptor in response to agonist binding and determination of a plausible molecular mechanism involved in activation ‘switch’ of the κ-opioid receptor. In absence of a crystal-based molecular structure of CCR5, a homology model of the receptor was built and the ligand binding pocket was validated. On the basis of evaluation of the ligand-receptor interactions on the validated binding pocket, structural and chemical modifications to anibamine, a natural plant product, were proposed to enhance its receptor binding. The selectivity of naltrexone (a universal antagonist) was assessed with respect to the three opioid receptors by employing ligand docking studies and the ‘message-address’ concept. Multiple address sites were identified on the opioid receptors and structural modifications were proposed for the naltrexone derivatives for their enhanced selectivity. In the third project, structural modeling of the active state conformation of the κ-opioid receptor covalently bound to a salvinorin A derivative (agonist) was attempted via molecular dynamics simulations. Although the obtained molecular model lacked the signature ‘agonist-like’ conformations, the result provides a template for such studies in the future.
32
Höglund, Pär J. "Identification, Characterization and Evolution of Membrane-bound Proteins." Doctoral thesis, Uppsala universitet, Institutionen för neurovetenskap, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-9329.
Full textAbstract:
Membrane proteins constitute approximately 30% of all genes in the human genome and two large families of membrane proteins are G protein-coupled receptors (GPCRs) and Solute Carriers (SLCs) with about 800 and 380 human genes, respectively. In Papers I, II and IV, we report 16 novel human Adhesion GPCRs found by searches in NCBI and Celera databases. In Paper I, we report eight novel human GPCRs, and six in Paper II. We identified two new human Adhesion GPCRs and 17 mouse orthologs in Paper IV. Phylogenetic analysis demonstrates that the 16 novel human genes are additional members of the Adhesion GPCR family and can be divided into eight phylogenetic groups. EST expression charts for the entire repertoire of Adhesions in human and mouse were established, showing widespread distribution in both central and peripheral tissues. Different domains were found in their N-terminus, some, such as pentraxin in GPR112, indicates that they take part in immunological processes. In Paper III, we discovered seven new human Rhodopsin GPCRs. In Paper V, we present the identification of two new human genes, termed SLC6A17 and SLC6A18 from the Solute Carriers family 6 (SLC6). We also identified the corresponding orthologs and additional genes from the mouse and rat genomes. We analysed, in total, 430 unique SLC6 proteins from 10 animal, one plant, two fungi and 196 bacterial genomes. In Paper VI, we provide the first systematic analysis of the evolutionary history of the different SLC families in Eukaryotes. In all, we analysed 2403 sequences in eight species and we delineate the evolutionary history of each of the 46 SLC families.
33
Charrette, Andrew. "The Role of the Central Region of the Third Intracellular Loop of D1-Class Receptors in Signalling." Thèse, Université d'Ottawa / University of Ottawa, 2012. http://hdl.handle.net/10393/23080.
Full textAbstract:
The D1-class receptors (D1R, D5R) each possess distinct signaling characteristics; however, pharmacological selectivity between them remains elusive. The third intracellular loops (IL3) of D1R and D5R harbour divergent residues that may contribute to their individual signalling phenotypes. Here we probe the function of central region of IL3 of D1R and D5R using deletion mutagenesis. Radioligand binding and whole cell cAMP assays suggest that the N-terminal and C-terminal moieties of the central IL3 oppositely contribute to the constitutive and agonist-dependant activity of D1-Class receptors. Whereas the N-terminal deletions ablated constitutive activity and decreased DA-induced activation, C-terminal deletions induced robust increases. These data, interpreted in concert with structural predictions generated from homology modeling implicate the central IL3 as playing an important role in the activation and subtype-specific characteristics of the D1-class receptors. This study may serve as a basis for the development of novel drugs targeting the central IL3 region.
34
Gandía, Sánchez Jorge. "Oligomerización del receptor A2A de adenosina: interpretando el receptorsoma." Doctoral thesis, Universitat de Barcelona, 2013. http://hdl.handle.net/10803/134352.
Full textAbstract:
Los receptores acoplados a proteína G (GPCR) conforman la familia de receptores de membrana más grande. El numeroso y variado tipo de señales que detectan han otorgado a estos receptores un alto interés farmacológico. Además, las interacciones entre diferentes tipos de GPCR formando complejos oligoméricos dan lugar a complejos con características bioquímicas diferenciadas de los protómeros que los forman. En esta Tesis Doctoral se han estudiado diferentes aspectos derivados este tipo de interacciones, centrando estos experimentos alrededor del receptor A2A de adenosina (A2AR), un importante neuromodulador del Sistema Nervioso Central.
Por una parte, mediante la combinación de las técnicas de transferencia de energía resonante bioluminiscente (BRET) y de complementación bimolecular fluorescente (BiFC) se ha podido detectar in vivo que A2AR forma oligómeros con más de dos protómeros, tanto de tipo homomérico (Gandía et al., 2008) como heteromérico. En este último caso, se ha estudiado en concreto el oligómero de A2AR con el receptor D2 de dopamina y el receptor metabotrópico 5 de glutamato (Cabello et al., 2009).
A continuación, se ha aplicado una variante de la técnica de doble híbrido específica para proteínas de membrana (MYTH), con la intención de detectar proteínas interaccionantes con A2AR. Gracias a esta aproximación, se han encontrado nuevas proteínas candidatas a interaccionar con nuestro receptor, destacando entre ellas un GPCR huérfano, GPR37.
Mediante técnicas físicas y funcionales en modelos de cultivo celular y animales se ha podido validar la interacción A2AR/GPR37 y se ha comprobado que la presencia de GPR37 modifica la funcionalidad del receptor A2A de adenosina.
Finalmente, para profundizar en las características estructurales de GPR37, poco conocidas hasta el momento, se ha estudiado la cola C-terminal del receptor. Así, se ha visto que existe una región rica en residuos de cisteína que regula el tráfico del receptor hacia la membrana plasmática. Además, este dominio rico en cisteínas modula el estrés de retículo endoplasmático generado al sobreexpresar GPR37 en cultivo celular y también la inducción de vías apoptóticas (actividad de caspasa-3) en estas mismas condiciones (Gandía et al., 2013).G protein-coupled receptors (GPCR) consitute the biggest family of membrane receptors. Since they detect a large and diverse number of signals, they have a growing pharmacological interest. Furthermore, the interactions between different types of GPCR form oligomeric complexes that show different biochemical properties than the protomers they are made of. Different aspects of these interactions have been studied in this Doctoral Thesis, focusing the experiments around the adenosine A2A receptor, being adenosine an important modulator of the Central Nervous System. Firstly, by means of the combination of the bioluminescent ressonant energy transfer (BRET) and bimolecular fluorescent combination (BiFC) techniques we have detected in vivo that A2AR is able to form oligomers made up of more than two protomers, leading to homomeric complexes (Gandía et al., 2008) as well as others of heteromeric nature. In this latter case, we have studied the oligomer of A2AR with the dopamine D2 and glutamate metabotropic 5 receptors (Cabello et al., 2009). Following these experiments, we have applied a modified version of the yeast two-hybrid technique set up for membrane proteins (MYTH) in order to detect A2AR-interacting proteins. Thanks to this approach, we have found new potential interactors, and among them an orphan GPCR has stood out: GPR37. By means of physical and functional techniques in cell culture and animal models we have validated the A2AR/GPR37 interaction and we have demonstrated that the presence of GPR37 modifies the functionality of A2AR. Finally, in order to better understand the rather less studied structural characteristics of GPR37, we have studied its C-terminal tail. Thus, we have observed the presence of a cysteine-rich region that regulates the trafficking of the receptor to the plasma membrane. Furthermore, this cystein-rich domain modulates the GPR37-dependent endoplasmic reticulum stress, as well as the induction of apoptotic pathways (capase-3 activity) (Gandía et al., 2013).
35
Åkerberg, Helena. "Functional Studies of the Neuropeptide Y System : Receptor-Ligand Interaction and Regulation of Food Intake." Doctoral thesis, Uppsala universitet, Institutionen för neurovetenskap, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-9533.
Full textAbstract:
The members of the mammalian neuropeptide Y family, i.e. the peptides neuropeptide Y (NPY), peptide YY (PYY) and pancreatic polypeptide (PP), are all involved in regulation of food intake. In human and most other mammals they act via receptors Y1, Y2, Y4 and Y5. NPY is released in the hypothalamus and is one of the strongest appetite-stimulating neurotransmitters whereas PP and PYY are secreted from gut endocrine cells after meals and function as appetite-reducing hormones. This thesis describes studies of the NPY system at both the molecular and the physiological level. The first part describes two investigations of receptor-ligand interactions with the human Y1 and Y2 receptors. The results clarify the importance of several amino-acid residues of the human Y1 receptor. Three amino acids previously suggested by others to form a binding pocket for the carboxy-terminus of the peptide were confirmed to be crucial for interaction with peptide ligands. However, they were found to be too distantly located from each other to be able to form a binding pocket. Further investigation of the three corresponding positions in the human Y2 receptor showed that only one of the positions was important for interaction with full-length peptides. The results indicate overlapping but, surprisingly, non-identical binding of the different peptides to human Y1 and Y2 receptors, despite the fact that the two receptors share a common ancestor. The second part of the thesis describes an investigation of the effect of PP on food intake in six beagle dogs and a test for personality characteristics in dogs (TFPC). Treatment with physiological doses of PP decreased both the appetitive and the consummatory drive but had no effect on the amount food consumed. The TFPC protocol was used to map individual behavioral differences in a population of sixteen beagle dogs. The test, which included several situations that may appear in an experimental study, revealed considerable inter-individual differences in behavioral responses despite the fact that the dogs were born and housed in the same animal facility in constant controlled conditions. These results demonstrate that PP can influence food intake in distantly related mammals and emphasize the importance of considering differences in personality in experimental animals.
36
Morgan, Rachel. "STRUCTURE-FUNCTION ANALYSIS OF THE DROSOPHILA STUBBLE TYPE II TRANSMEMBRANE SERINE PROTEASE." Master's thesis, University of Central Florida, 2008. http://digital.library.ucf.edu/cdm/ref/collection/ETD/id/3536.
Full textAbstract:
Hormonally-triggered regulatory hierarchies play a major role in organismal development. Disruption of a single member of such a hierarchy can lead to irregular development and disease. Therefore, knowledge of the members involved and the mechanisms controlling signaling through such pathways is of great importance in understanding how resulting developmental defects occur. Type II transmembrane serine proteases (TTSPs) make up a family of cell surface-associated proteases that play important roles in the development and homeostasis of a number of mammalian tissues. Aberrant expression of TTSPs is linked to several human disorders, including deafness, heart and respiratory disease and cancer. However, the mechanism by which these proteases function remains unknown. The ecdysone-responsive Stubble TTSP of Drosophila serves as a good model in which to study the functional mechanism of the TTSP family. The Stubble protease interacts with the intracellular Rho1 (RhoA) pathway to control epithelial development in imaginal discs. The Rho1 signaling pathway regulates cellular behavior via control of gene expression and actin cytoskeletal dynamics. However, the mechanism by which the Stubble protease interacts with the Rho1 pathway to control epithelial development, in particular leg imaginal disc morphogenesis, has yet to be elucidated. The Stubble protein consists of several conserved domains. One approach to a better understanding of the mechanism of action of Stubble in regulating Rho1 signaling is to define which of the conserved domains within the protease are required for proper function. Sequence analysis of twelve recessive Stubble mutant alleles has revealed that the proteolytic domain is essential for proper function. Alleles containing mutations which disrupt regions of the protease domain necessary for protease activation or substrate binding, as well as those with deletions or truncations that remove some portion of the proteolytic domain, result in defective epithelial development in vivo. In contrast, mutations in other regions of the Stubble protein, including the disulfide-knotted and cytoplasmic domains, were not observed. Another important step for defining the connection between Stubble and Rho1 signaling is to identify a Stubble target that acts as an upstream regulator of the Rho1 pathway. We performed a genetic screen in which 97 of the 147 Drosophila non-olfactory and non-gustatory G-protein-coupled receptors (GPCRs), a family of proteins that has been shown to be protease-activated and to activate Rho1 signaling, were tested for interactions with a mutant allele of Stubble. We found 4 genomic regions uncovering a total of 7 GPCRs that interact genetically when in heterozygous combination with a Stubble mutant. Further analysis of these genes is necessary to determine if any of these GPCRs is targeted by Stubble during activation of the Rho1 pathway.M.S.
Department of Biology
Sciences
Biology MS
37
van, Bysterveldt Katherine. "Role of G Protein-coupled Receptor Kinase 5 in Desensitisation of the V1b Vasopressin Receptor in Response to Arginine Vasopressin." Thesis, University of Canterbury. Biological Sciences, 2011. http://hdl.handle.net/10092/6214.
Full textAbstract:
Arginine vasopressin (AVP) is a hypothalamic nonapeptide which regulates the hypothalamic-pituitary-adrenal axis response to stress by stimulating the secretion of adrenocorticotropin (ACTH) from corticotroph cells of the anterior pituitary. This effect is mediated by binding of AVP to the pituitary vasopressin receptor (V1bR). The V1bR belongs to the G protein-coupled receptor (GPCR) super family. Repeated stimulation of anterior pituitary cells with AVP has been shown to produce a loss of responsiveness to subsequent AVP stimulation. This phenomenon appears to be mediated by desensitisation of the V1bR, and may be due to phosphorylation of the receptor by G protein-coupled receptor kinase 5 (GRK5). The aim of this research was to establish and validate methods that would allow the role of GRK5 in the desensitisation of V1bR to AVP stimulation to be investigated. As no isoform specific inhibitors for GRK5 were available, HEK293 cells transiently transfected with the rat V1bR were used as a model system for this research. This allowed RNA interference (RNAi) to be used to knockdown GRK5 expression. The protocol for RNAi-mediated knockdown of GRK5 was established as part of this research. Protocols for Western blotting and qRT-PCR were also established to allow the RNAi-mediated knockdown of GRK5 protein and mRNA to be measured. Transfection of HEK293 cells with 10nM GRK5-targeting small interfering RNAs (siRNAs) reduced the expression of GRK5 protein to 53.4% ± 3.4% (mean ± SEM) of that seen in untreated control cells at 84 hours after transfection, while GRK5 mRNA levels were reduced to 28.7% ± 1.9% (mean ± SEM) of that of control cells 48 hours after transfection.
An experimental protocol was designed in this research that would coordinate the RNAi-mediated knockdown of GRK5 with transient transfection of the HEK293 cells with the rV1bR. Since, activated V1bRs couple to Gq/11 and stimulate the production of inositol phosphates (IPs), the responsiveness of the V1bR can be determined by measuring the accumulation of [H³]-IPs in cells labelled with [H³]-myo-inositol. In the protocol designed, the effect of GRK5 knockdown on V1bR desensitisation is determined by stimulating HEK293 cells expressing the rV1bR (and previously transfected with GRK5-targeting siRNA) with 0nM or 100nM AVP for 0, 5, 15, 30 or 60 minutes, and comparing the accumulation if IPs over time with that of cells that are not transfected with GRK5-targeting siRNA. This protocol can be used in future to investigate the role of GRK5 in V1bR desensitisation, and may be adapted to determine if other GRK isoforms are involved in V1bR desensitisation.
38
Davidsson, Anton. "Challenging specificity of chemicalcompounds targeting GPCRs with cellprofiling." Thesis, Uppsala universitet, Institutionen för biologisk grundutbildning, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420682.
Full textAbstract:
Screening compounds with image-based analysis is an important part in the processof drug discovery. It is an efficient way to screen compounds as it gives moreinformation than for example HTS. High-content screening as it is also called, hasreally progressed in recent years, as the field of data science evolves, and with it sodoes the efficiency of how images can be processed into information. Anotherimportant part of the drug discovery field is the family of receptors GPCRs, a largefamily of over 800 different receptors in humans. The reason GPCRs are importantin drug discovery is because of the large number of drugs targeting them. In thisexperiment we wanted to use image-based analysis to challenge drugs orcompounds that were said to be specific and see if they actually are that specific, orif we can see indications of the drug also working somewhere else. While the drugswe tested did not appear to cause any morphological perturbations large enough todistinguish them from the control, some drugs appear to cluster differently. Thismight suggest that they affect multiple targets, but it needs to be followed up upon inorder to draw any substantial conclusions.
39
Boukharta, Lars. "Computational Modelling of Ligand Complexes with G-Protein Coupled Receptors, Ion Channels and Enzymes." Doctoral thesis, Uppsala universitet, Beräknings- och systembiologi, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-212103.
Full textAbstract:
Accurate predictions of binding free energies from computer simulations are an invaluable resource for understanding biochemical processes and drug action. The primary aim of the work described in the thesis was to predict and understand ligand binding to several proteins of major pharmaceutical importance using computational methods. We report a computational strategy to quantitatively predict the effects of alanine scanning and ligand modifications based on molecular dynamics free energy simulations. A smooth stepwise scheme for free energy perturbation calculations is derived and applied to a series of thirteen alanine mutations of the human neuropeptide Y1 G-protein coupled receptor and a series of eight analogous antagonists. The robustness and accuracy of the method enables univocal interpretation of existing mutagenesis and binding data. We show how these calculations can be used to validate structural models and demonstrate their ability to discriminate against suboptimal ones. Site-directed mutagenesis, homology modelling and docking were further used to characterize agonist binding to the human neuropeptide Y2 receptor, which is important in feeding behavior and an obesity drug target. In a separate project, homology modelling was also used for rationalization of mutagenesis data for an integron integrase involved in antibiotic resistance. Blockade of the hERG potassium channel by various drug-like compounds, potentially causing serious cardiac side effects, is a major problem in drug development. We have used a homology model of hERG to conduct molecular docking experiments with a series of channel blockers, followed by molecular dynamics simulations of the complexes and evaluation of binding free energies with the linear interaction energy method. The calculations are in good agreement with experimental binding affinities and allow for a rationalization of three-dimensional structure-activity relationships with implications for design of new compounds. Docking, scoring, molecular dynamics, and the linear interaction energy method were also used to predict binding modes and affinities for a large set of inhibitors to HIV-1 reverse transcriptase. Good agreement with experiment was found and the work provides a validation of the methodology as a powerful tool in structure-based drug design. It is also easily scalable for higher throughput of compounds.
40
Noël, Cynthia Jenny. "Modulation orthostérique et allostérique du PAFR par des molécules synthétiques." Mémoire, Université de Sherbrooke, 2008. http://savoirs.usherbrooke.ca/handle/11143/3974.
Full textAbstract:
Le PAF (facteur d'activation des plaquettes) est un médiateur lipidique de l'inflammation très puissant impliqué dans plusieurs conditions pathophysiologiques.Le PAF agit principalement via un seul récepteur, le PAFR qui appartient à la famille des récepteurs couplés aux protéines G, les GPCRs. Le"two state model" assume que les GPCRs existent dans un état d'équilibre entre un état inactif (R) et un état actif (R*). L'isomérisation de R vers R* peut arriver de façon spontanée, c'est à dire indépendamment de la liaison d'un agoniste. Dans ces travaux de recherche, nous avons tenté de déterminer la propriété antagoniste et agoniste inverse des molécules orthostériques (WEB2086, PCA4248, FR49175, bromure d'octylonium, CV3988 et le Trans BTP dioxolane) à activer la voie des MAPK ainsi que le cycle biochimique des inositols phosphates dans la lignée cellulaire HEK 293 transfectée de façon stable avec le récepteur du PAF. De plus, l'activité potentiellement allostérique sur le PAFR de modulateurs synthétiques tels le THG-315, le THG-316 et MAREK a également été investiguée dans la même lignée cellulaire. Finalement, des surnageants d'hybridome 9H1/1C1, 9F5/1H4, 9F5/1H4, 9F5/1F8, 9F5/2B3 et 9F5/2E4 contenant des anticorps monoclonaux, dirigés tous contre un peptide qui équivaut à la région C-terminale de la troisième boucle extracellulaire du PAFR: GFQDSKfHQA ont également été utilisés, afin : (1) de déterminer le meilleur clone en terme d'affinité et de spécificité et (2) effectuer des tests pour savoir s'ils possèdent des propriétés agonistes ou antagonistes sur le PAFR. En conclusion, les résultats obtenus nous indiquent que : (1) l'efficacité des molécules orthostériques à antagoniser les réponses induites par le PAF dépend de leur nature et de leur concentration, (2) les modulateurs potentiellement allostériques utilisés ne modulent aucune des voies majoritairement connues pour être activées par le PAFR, et (3) qu'il n'y a aucun marquage spécifique du PAFR avec les surnageants d'hybridomes utilisés.
41
Niescierowicz, Katarzyna. "Développement de la technologie des récepteurs couplés à un canal ionique pour des études structure-fonction des récepteurs couplés aux protéines G et du canal Kir6.2." Phd thesis, Université de Grenoble, 2013. http://tel.archives-ouvertes.fr/tel-01067669.
Full textAbstract:
Les Récepteurs Couplés à un Canal Ionique (ICCRs) sont des canaux ioniques artificielscréés par fusion d'un Récepteur Couplé aux Protéines G (RCPG) au canal ionique Kir6.2. Dansce concept, le canal agit comme un rapporteur direct des changements conformationnels desRCPGs permettant de détecter par simple mesure de courant, la fixation d'agonistes etd'antagonistes proportionnellement à leur concentration.Le signal induit étant directement corrélé à l'activité du récepteur, indépendamment desvoies de signalisation des protéines G, nous avons exploité cet avantage pour étendre le champd'applications des ICCRs au cours de cette thèse. Nous avons développé quatre applications quisont: 1) la caractérisation fonctionnelle des RCPG optimisés pour la cristallisation par insertionde domaine du lysozyme du phage T4 dans la boucle ICL3; 2) la détection de la dépendance desRCPGs au cholestérol; 3) la détection de ligands dits "biaisés" pour faciliter leur criblage; et 4) lacartographie fonctionnelle des portes du canal Kir6.2 régulées par des protéines membranairesinteragissant par le domaine N-terminal.
42
Ladarré, Delphine. "Neuronal polarization shapes the targeting and signaling of G-protein coupled receptors (GPCRs) : type-1 cannabinoid receptors and 5-HT1B serotonin receptors show highly contrasted trafficking and signaling patterns in axons and dendrites." Thesis, Paris 5, 2014. http://www.theses.fr/2014PA05T070/document.
Full textAbstract:
L’architecture polarisée des neurones est mise en place est maintenue grâce à un adressage hautement contrôlé de protéines vers l’axone ou vers le compartiment somatodendritique. Parmi ces protéines, les récepteurs aux protéines G (RCPG) neuronaux sont des cibles pharmacologiques clés. Cependant, leur pharmacologie est généralement étudiée dans des lignées cellulaires non polarisées et les résultats obtenus dans ces systèmes ne caractérisent pas correctement les effets physiologiques de l’activation des RCPG présents dans le cerveau. Par conséquent, un des principaux sujets de recherche de notre équipe est de comprendre comment la polarité neuronale influe sur la pharmacologie des RCPG, en étudiant l’un des RCPG les plus abondants dans le cerveau : le récepteur cannabinoïque de type-1 (CB1R). Les études précédentes de notre groupe ont suggéré que CB1R acquiert une polarisation axonale grâce à un adressage transcytotique : après leur synthèse, ces récepteurs apparaissent sur la membrane plasmique somatodendritique d’où ils sont rapidement enlevés par endocytose constitutive puis adressés à la membrane plasmique axonale où ils s’accumulent du fait d’une endocytose réduite. Au début de ma thèse, nous avons directement mesuré cette endocytose différentielle et le transport transcytotique de CB1R en utilisant des neurones de rats mis en culture dans des dispositifs microfluidiques. De plus, nous avons montré que des traitements pharmacologiques prolongés peuvent fortement changer la distribution de RCPG à la surface neuronale. Ces résultats démontrent que l’équilibre endocytotique dépendant du compartiment neuronal, qui est contrôlable pharmacologiquement, est important pour la distribution des RCPG neuronaux. Dans une seconde partie, nous avons étudié si le trafic différentiel de CB1R entre axones et dendrites est corrélé avec une pharmacologie différentielle. CB1R est majoritairement couplé à des protéines de type Gi/o et est connu pour inhiber la production d’AMPc. Nous avons donc développé l’imagerie par Föster Resonance Energy Transfer (FRET) appliqué aux cultures de neurones d’hippocampe de rats afin de mesurer la modulation de la voie de signalisation AMPc/PKA en aval de CB1R endogènes dans l’ensemble des compartiments neuronaux : somata, dendrites, mais aussi dans les axones matures très fins. Nos résultats montrent que CB1R possède une pharmacologie différente entre les dendrites et les axones. Notamment, son activation conduit à une diminution plus forte de l’activité basale de la PKA dans les axones comparé aux dendrites, lié au plus grand nombre de récepteurs présents sur la membrane de ce compartiment. De plus, nous démontrons que, contrairement aux récepteurs axonaux, les CB1R somatodendritiques inhibent constitutivement la voie AMPc/PKA. Cette différence est due à la distribution polarisée de la DAGLipase, l’enzyme synthétisant l’endocannabinoïde principal, le 2-arachidonoyglycerol (2-AG). De plus, l’inhibition pharmacologique de la DAGL modifie l’efficacité de plusieurs agonistes de CB1R dans le compartiment somatodendritique mais pas dans l’axone. Cet effet pourrait être dû à une modulation allostérique. Dans une troisième partie, nous avons étudié si les résultats ci-dessus peuvent être généralisés à d’autres RCPG. Etant donné que l’adressage axonal et la pharmacologie in vitro des récepteurs sérotoninergiques 5-HT1B montrent de fortes similitudes avec ceux de CB1R, nous avons étudié la pharmacologie de ces récepteurs en utilisant la technique de FRET développée précédemment. De façon similaire, nous avons trouvé une pharmacologie différentielle entre l’axone et les dendritesPolarized neuronal architecture is achieved and maintained mainly through highly controlled targeting of proteins to axons versus to the somatodendritic compartment. Among these proteins, neuronal G protein coupled receptors (GPCRs) are key therapeutic targets. However, their pharmacology is generally studied in non-polarized cell lines, and results obtained in such systems likely do not fully characterize the physiological effects of brain GPCR activation. Therefore, a main research subject of our group is to understand how neuronal polarity influences GPCR pharmacology, by studying one of the most abundant GPCR in the brain: the type-1 cannabinoid receptor (CB1R). Previous studies of the group suggested that CB1Rs achieve axonal polarization through transcytotic targeting: after their synthesis, these receptors appear on the somatodendritic plasma membrane from where they are removed rapidly by constitutive endocytosis and then targeted to the axonal plasma membrane where they accumulate due to relatively reduced endocytosis rate. At the beginning of my PhD project we directly demonstrated this differential endocytosis and transcytotic transport of CB1Rs by using cultured neurons in microfluidic devices. Moreover, we showed that chronic pharmacological treatments may strongly change neuronal GPCR distribution on the neuronal surface. These results demonstrate that subdomain-dependent steady-state endocytosis, which is pharmacologically controllable, is important for GPCR distribution in neurons. In a second part, we asked if differential traffic of CB1Rs between axons and dendrites is correlated with differential pharmacology. CB1R is predominantly coupled to Gi/o proteins and is known to inhibit cAMP production. Thus, we developed live Föster Resonance Energy Transfer (FRET) imaging in cultured hippocampal neurons in order to measure basal cAMP/PKA pathway modulation downstream of endogenous CB1Rs in all neuronal compartments: in somata, in dendrites but also in the very thin mature axons. Our results show that CB1R displays differential pharmacology between axon and dendrites. Notably, its activation leads to a stronger decrease of PKA activity in axons compared to dendrites, due to increased number of membrane receptors in this compartment. Moreover, we demonstrate that somatodendritic CB1Rs constitutively inhibit cAMP/PKA pathway, while axonal receptors do not. This difference is due to polarized distribution of DAGLipase, the enzyme that synthesizes the major endocannabinoid 2-arachidonoylglycerol (2-AG). Moreover, blocking DAGL by pharmacological treatment modifies somatodendritic, but not axonal effects of several CB1R agonists, possibly through allosteric action. In a third part, we asked if the above results may be generalized to other GPCRs. Because the axonal targeting and in vitro pharmacology of 5-HT1B serotonin receptors demonstrate strong similarities with CB1Rs, we studied their neuronal pharmacology by using the previously developed FRET technique. We found similar differential responses to pharmacological treatments between axon and dendrites. In a fourth part, we investigated the role of the threonine 210 (T210) residue in the constitutive activity of neuronal CB1R. We showed that the hypoactive mutant T210A-CB1R do not constitutively recruit signaling pathways even in somatodendritic compartment, where 2-AG is present. This result demonstrates that T210 is necessary for constitutive CB1R activation by 2-AG.Finally, previous results of our group demonstrated the involvement of CB1R in neuronal development. Notably, CB1R activation was shown to have an overall inhibitory effect on the development of polarized neuronal morphology. We established a bibliographic review on this subject. The published literature data suggest that not only neuronal polarization influences both CB1R traffic and pharmacology but CB1Rs also contribute to the achievement of neuronal polarization. (...)
43
Cummings, Siobhan Anne. "Desensitisation of the Pituitary Vasopressin Receptor: Development and Use of a Stably-Transfected Model Cell System to Assess the Role of G Protein-Coupled Receptor Kinases." Thesis, University of Canterbury. School of Biological Sciences, 2011. http://hdl.handle.net/10092/5351.
Full textAbstract:
Stress impacts upon all organisms and a robust stress response is required for adaptive interactions of the organism with the environment. In most higher organisms, an individual’s response to stress is mediated by the hypothalamic pituitary adrenal (HPA) axis. Inappropriate regulation of this axis can cause debilitating mental health disorders including depression and anxiety. These disorders can affect an individual’s ability to interact and respond appropriately as different situations arise.
An important component of this axis is the vasopressin V1b receptor (V1bR), which mediates adrenocorticotropin (ACTH) secretion from the anterior pituitary in response to stimulation by arginine vasopressin (AVP). AVP also potentiates the ACTH secretion mediated by corticotropin-releasing hormone type 1 receptor (CRH-R1) in response to corticotropin- releasing hormone (CRH) stimulation. Both the V1bR and CRH-R1 are G protein coupled receptors (GPCRs). A common feature of GPCR signalling is desensitisation of the response following prolonged or repeated exposure to an agonist. Phosphorylation of the receptor is one of the mechanisms of desensitisation. This directly, or indirectly, results in rapid and reversible uncoupling of the receptor from its heterotrimeric guanine nucleotide binding protein (G-protein). Previous research has shown that G protein coupled receptor kinases (GRKs) are key phosphorylators involved in the molecular mechanism of GPCR desensitisation. One of the mains goals of the research carried out in the Mason laboratory is to examine the molecular mechanisms of V1bR desensitisation. The current short term aim is to examine the potential role for GRKs in this mechanism.
It is difficult to study a single receptor type and the molecular mechanisms involved in its regulation in a system larger than a cell based assay. As the proposed method of assessing the involvement of GRKs in desensitisation of the V1bR is to use RNA interference (RNAi) to knock down the expression of the GRKs, primary cell cultures of pituitary corticotrophs are an inappropriate choice. This is due to a number of factors, including the difficulty involved in transfecting primary cells, and the difficulty involved in interpreting the results from primary cell culture experiments as these cultures are composed heterogenous population of cells. Therefore, the main aim of this research was to develop a model cell system from an immortalised cell line, stably-transfected with the V1bR, in which the involvement of GRKs in the molecular mechanism of V1bR desensitisation could be studied. Development of stably-transfected cell lines requires substantial preliminary work and planning in order to produce a successful outcome. Once developed, characterisation of the clonal cell lines is required.
The preliminary work involved determining the cell proliferation rate of the parental cell line, plasmid sub-cloning and production of a large quantity of plasmid DNA, optimisation of the antibiotic selection conditions, and optimisation of the transfection protocol, as well as modification of the inositol phosphate (IP) assay protocol. The V1bR activates the phospholipase Cβ (PLCβ) second messenger signalling pathway in response to stimulation with AVP. This results in the production of IPs and therefore, measurement of IPs in response to AVP stimulation of cells labelled with myo-[³H]inositol can be used as an indicator of functional V1bR expression.
In this research a total of nine clonal cell lines resistant to the antibiotic G418 were generated.
Initial testing of these lines indicated that four probably expressed the V1bR and these were
selected for characterisation in greater detail. All of these four lines showed significantly
increased IP production in response to AVP stimulation (P<0.05; t-test). A significant
decrease in IP production in response to AVP stimulation following an AVP pre-treatment
was also seen with all four lines (P<0.05; t-test). Current evidence therefore suggests that the
V1bR in these clonal cell lines signals and desensitises in the normal way. Although further
characterisation of the clonal cell line is desirable, the data to date indicate that these lines
should be considered to provide an appropriate model system for examining the molecular
mechanisms involved in the regulation of the V1bR. It appears that there are some minor
differences in signalling between the clonal cell lines and therefore this should be a
consideration when deciding which line is most appropriate to use for investigating a
particular question.
44
Deupí, i. Corral Xavier. "Influence of Ser and Thr residues in the geometry of transmembrane helices: implications on the structure and function of G protein-coupled receptors." Doctoral thesis, Universitat Autònoma de Barcelona, 2003. http://hdl.handle.net/10803/4426.
Full textAbstract:
En aquesta tesi s'apliquen eines bioinformàtiques a l'estudi de determinats sistemes biològics. En particular, l'estudi teòric de la influència de determinats aminoàcids sobre l'estructura i la dinàmica dels elements d'estructura secundària de les proteïnes s'aplica a la modelització per homologia dels receptors acoblats a proteïna G (GPCRs) i a l'estudi dels seus mecanismes d'activació.Se sap que determinats residus, com prolina, serina o treonina, provoquen distorsions locals en l'estructura de les hèlices a. L'anàlisi de bases de dades de seqüències de segments transmembrana mostra com certes combinacions d'aquests residus són més comunes que d'altres, i que algunes d'elles estan sobre-representades de manera significativa, mentre que d'altres estan clarament sots-representades. La restricció d'aquesta anàlisi de seqüències a la regió transmembrana dels GPCRs de la Classe A mostra com aquestes combinacions es troben en posicions específiques i, a més, es troben conservades en certes subfamílies de receptors.
L'estructura i la dinàmica de les hèlices transmembrana que contenen aquestes combinacions de prolina i serina o treonina s'han estudiat mitjançant simulacions de dinàmica molecular en un entorn hidrofòbic explícit. Els resultats mostren com algunes d'aquestes combinacions indueixen distorsions importants en l'estructura de l'hèlix a, degut al seu efecte desestabilitzador de la xarxa de ponts d'hidrogen que dóna estabilitat a l'hèlix.
Aquests resultats s'han aplicat a la construcció d'un model tridimensional del receptor de quimiocines CCR5 , utilitzant tècniques de modelització molecular per homologia. En aquest model es proposa que les hèlices transmembrana (TMH) 2 i 3 del receptor CCR5 són estructuralment diferents del patró de rodopsina. TMH2 està més doblegada degut a la presència d'un motiu Thr-X-Pro, que, a més, fa que aquesta hèlix es doblegui cap a TMH3. Així doncs, es proposa que, en aquest receptor, aquestes dues hèlices interaccionen. Aquesta interacció estaria mediada per la presència de residus hidrofòbics conservats i específics en les dues hèlices. Aquestes hipòtesis han estat posades a prova mitjançant experiments de mutagènesi dirigida, gràcies a la col·laboració amb l'Institut de Recherche Interdisciplinaire en Biologie Humaine et Nucléaire (IRIBHN), Université Libre de Bruxelles. Els resultats experimentals permeten establir la hipòtesi que la interfície TMH2-TMH3 participa en l'activació induïda per quimiocines del receptor CCR5.
Com a conclusió, aquesta tesi pretén mostrar com, mitjançant la utilització d'eines bioinformàtiques, és possible traduir les seqüències primàries de proteïnes i les interaccions a nivell atòmic en estructures tridimensionals de proteïnes. A més, aquesta tesi mostra que, encara que l'estructura tridimensional de la rodopsina bovina és un patró útil per la modelització per homologia de GPCRs, s'han de tenir en compte de manera explícita les especificitats de seqüència de cada receptor per tal de construir models de receptors particulars. Aquestes especificitats de seqüència consisteixen en patrons de seqüència conservats en determinades famílies, que es tradueixen en divergències estructurals. Entre aquests patrons de seqüència, es proposa que els residus de serina i treonina, sols o combinats amb residus de prolina propers, poden modular la geometria de les TMHs, degut a la seva capacitat d'interferir amb la xarxa de ponts d'hidrogen que dóna estabilitat a les hèlices a.
Finalment, es proposa que la influència dels motius de serina, treonina i prolina en l'estructura de les TMHs pot estar relacionada amb els processos d'activació dels GPCRs de la Classe A i, possiblement, d'altres proteïnes de membrana. En els GPCRs, aquests motius poden haver evolucionat per tal d'adaptar uns mecanismes d'activació conservats als lligands característics de cada família de receptors.
This thesis is framed in the study of particular biological systems through the use of bioinformatics. In particular, the theoretical study of the influence of certain amino acids on the structure and dynamics of the secondary structure elements of proteins has been applied to homology modelling of G protein-coupled receptors (GPCRs) and to the study of their mechanisms of activation.
Certain residues, as proline, serine or threonine, are known to induce local distortions in the a-helical structure. Analysis of sequence databases of transmembrane segments evidence that certain combinations of these residues are more common than others, and that some of them are significantly over-represented, while others are clearly under-represented. The focusing this sequence analysis on the transmembrane region of Class A GPCRs illustrates that these combinations are located in some specific locations and conserved within certain subfamilies of receptors.
The structure and dynamics of transmembrane a-helices containing these combinations of proline and serine or threonine have been studied using molecular dynamics simulations in an explicit hydrophobic environment. The results show how some of these combinations induce significant distortions in the a-helical structure, due to their effect on the hydrogen bond network that stabilizes the helix.
These results have been applied to the building of a three-dimensional model of the chemokine CCR5 receptor, using homology modelling techniques. In this model, transmembrane helices (TMH) 2 and 3 of CCR5 are proposed to be different from the bovine rhodopsin template. TMH2 is more bent due to the presence of a Thr-X-Pro motif, which, in turn, induces this helix to lean towards TMH3. As a consequence, an interaction between these two helices is proposed for this particular receptor. This interaction would be mediated through the presence of specific and conserved hydrophobic and aromatic residues in both helices. These hypothesis have been tested through site-directed mutagenesis experiments, thanks to a collaboration with the Institut de Recherche Interdisciplinaire en Biologie Humaine et Nucléaire (IRIBHN), Université Libre de Bruxelles. The experimental results let us to hypothesize that the TMH2-TMH3 interface is involved in the chemokine-induced activation of the CCR5 receptor.
As a conclusion, this thesis aims to show how through the use of bioinformatics tools, primary sequences of proteins and interactions at an atomic level can be translated to three-dimensional protein structures. In addition, this thesis illustrates that, even though the three-dimensional structure of bovine rhodopsin is a very useful template for homology modelling of GPCRs, the sequence specificities of each receptor have to be explicitly taken into account in order to build models. These sequence specificities consist in sequence patterns conserved within certain families, which are translated into structural divergences. Among these sequence patterns, we hypothesize that serine and threonine, alone or combined with nearby proline residues, can modulate the geometry of TMHs, due to its capability to interfere with the hydrogen bond network that stabilize a-helices.
Finally, we propose that the influence of serine, threonine and proline motifs in the structure of TMHs may be related to processes of activation in the Class A of GPCRs, and, possibly, other membrane proteins as well. In GPCRs, these motifs may have evolved in order to adapt a conserved mechanism of activation of the G protein to the cognate ligands of each receptor family.
45
Adams, Mark N. "In vitro and in vivo studies on protease-activated receptor-2." Thesis, Queensland University of Technology, 2012. https://eprints.qut.edu.au/54338/1/Mark__Adams_Thesis.pdf.
Full textAbstract:
Protease-activated receptor-2 (PAR2) is a G protein coupled receptor (GPCR) that is activated by proteolytic cleavage of its amino terminal domain by trypsin-like serine proteases. Cleavage of this receptor exposes a neoepitope, termed the tethered ligand (TL), which binds intramolecularly within the receptor to stimulate signal transduction via coupled G proteins. PAR2-mediated signal transduction is also experimentally stimulated by hexapeptides (agonist peptides; APs) that are homologous to the TL sequence. Due to the irreversible nature of PAR2 proteolysis, downstream signal transduction is tightly regulated. Following activation, PAR2 is rapidly uncoupled from downstream signalling by the post-translational modifications phosphorylation and ubiquination which facilitate interactions with â- arrestin. This scaffolding protein couples PAR2 to the internalisation machinery initiating its desensitisation and trafficking through the early and late endosomes followed by receptor degradation.
PAR2 is widely expressed in mammalian tissues with key roles for this receptor in cardiovascular, respiratory, nervous and musculoskeletal systems. This receptor has also been linked to pathological states with aberrant expression and signalling noted in several cancers. In prostate cancer, PAR2 signalling induces migration and proliferation of tumour derived cell lines, while elevated receptor expression has been noted in malignant tissues. Importantly, a role for this receptor has also been suggested in prostate cancer bone metastasis as coexpression of PAR2 and a proteolytic activator has been demonstrated by immunohistochemical analysis.
Based on these data, the primary focus of this project has been on two aspects of PAR2 biology. The first is characterisation of cellular mechanisms that regulate PAR2 signalling and trafficking. The second aspect is the role of this receptor in prostate cancer bone metastasis. In addition, to permit these studies, it was first necessary to evaluate the specificity of the commercially available anti-PAR2 antibodies SAM11, C17, N19 and H99. The evaluation of the four commercially available antibodies was assessed using four techniques: immunoprecipitation; Western blot analysis; immunofluorescence; and flow cytometry. These approaches demonstrated that three of the antibodies efficiently detect ectopically expressed PAR2 by each of these techniques. A significant finding from this study was that N19 was the only antibody able to specifically detect N-glycosylated endogenous PAR2 by Western blot analysis. This analysis was performed on lysates from prostate cancer derived cell lines and tissue derived from wildtype and PAR2 knockout mice. Importantly, further evaluation demonstrated that this antibody also efficiently detects endogenous PAR2 at the cell surface by flow cytometry.
The anti-PAR2 antibody N19 was used to explore the in vitro role of palmitoylation, the post-translational addition of palmitate, in PAR2 signalling, trafficking, cell surface expression and desensitization. Significantly, use of the palmitoylation inhibitor 2-bromopalmitate indicated that palmitate addition is important in trafficking of PAR2 endogenously expressed by prostate cancer cell lines. This was supported by palmitate labelling experiments using two approaches which showed that PAR2 stably expressed by CHO cells is palmitoylated and that palmitoylation occurs on cysteine 361. Another key finding from this study is that palmitoylation is required for optimal PAR2 signalling as Ca2+ flux assays indicated that in response to trypsin agonism, palmitoylation deficient PAR2 is ~9 fold less potent than wildtype receptor with a reduction of about 33% in the maximum signal induced via the mutant receptor. Confocal microscopy, flow cytometry and cell surface biotinylation analyses demonstrated that palmitoylation is required for efficient cell surface expression of PAR2. Importantly, this study also identified that palmitoylation of this receptor within the Golgi apparatus is required for efficient agonist-induced rab11amediated trafficking of PAR2 to the cell surface. Interestingly, palmitoylation is also required for receptor desensitization, as agonist-induced â-arrestin recruitment and receptor degradation were markedly reduced in CHO-PAR2-C361A cells compared with CHO-PAR2 cells. Collectively, these data provide new insights on the life cycle of PAR2 and demonstrate that palmitoylation is critical for efficient signalling, trafficking, cell surface localization and degradation of this receptor. This project also evaluated PAR2 residues involved in ligand docking. Although the extracellular loop (ECL)2 of PAR2 is known to be required for agonist-induced signal transduction, the binding pocket for receptor agonists remains to be determined. In silico homology modelling, based on a crystal structure for the prototypical GPCR rhodopsin, and ligand docking were performed to identify PAR2 transmembrane (TM) amino acids potentially involved in agonist binding. These methods identified 12 candidate residues that were mutated to examine the binding site of the PAR2 TL, revealed by trypsin cleavage, as well as of the soluble ligands 2f-LIGRLO-NH2 and GB110, which are both structurally based on the AP SLIGRLNH2.
Ligand binding was evaluated from the impact of the mutated residues on PAR2-mediated calcium mobilisation. An important finding from these experiments was that mutation of residues Y156 and Y326 significantly reduced 2f-LIGRLO-NH2 and GB110 agonist activity. L307 was also important for GB110 activity.
Intriguingly, mutation of PAR2 residues did not alter trypsin-induced signalling to the same extent as for the soluble agonists. The reason for this difference remains to be further examined by in silico and in vitro experimentation and, potentially, crystal structure studies. However, these findings identified the importance of TM domains in PAR2 ligand docking and will enhance the design of both PAR2 agonists and potentially agents to inhibit signalling (antagonists).
The potential importance of PAR2 in prostate cancer bone metastasis was examined using a mouse model. In patients, prostate cancer bone metastases cause bone growth by disrupting bone homeostasis. In an attempt to mimic prostate cancer growth in bone, PAR2 responsive 22Rv1 prostate cancer cells, which form mixed osteoblastic and osteolytic lesions, were injected into the proximal aspect of mouse tibiae. A role for PAR2 was assessed by treating these mice with the recently developed PAR2 antagonist GB88. As controls, animals bearing intra-tibial tumours were also treated with vehicle (olive oil) or the prostate cancer chemotherapeutic docetaxel. The effect of these treatments on bone was examined radiographically and by micro-CT.
Consistent with previous studies, 22Rv1 tumours caused osteoblastic periosteal spicule formation and concurrent osteolytic bone loss. Significantly, blockade of PAR2 signalling reduced the osteoblastic and osteolytic phenotype of 22Rv1 tumours in bone. No bone defects were detected in mice treated with docetaxel.
These qualitative data will be followed in the future by quantitative micro-CT analysis as well as histology and histomorphometry analysis of already collected tissues. Nonetheless, these preliminary experiments highlight a potential role for PAR2 in prostate cancer growth in bone.
In summary, in vitro studies have defined mechanisms regulating PAR2 activation, downstream signalling and trafficking and in vivo studies point to a potential role for this receptor in prostate cancer bone metastasis. The outcomes of this project are that a greater understanding of the biology of PAR2 may lead to the development of strategies to modulate the function of this receptor in disease.
46
Röser, Claudia. "Charakterisierung der Serotonin-Rezeptoren in den Speicheldrüsen von Calliphora vicina." Phd thesis, Universität Potsdam, 2012. http://opus.kobv.de/ubp/volltexte/2012/6148/.
Full textAbstract:
Die Fähigkeit, mit anderen Zellen zu kommunizieren, ist eine grundlegende Eigenschaft aller lebenden Zellen und essentiell für die normale Funktionsweise vielzelliger Organismen. Die Speicheldrüsen der Schmeißfliege Calliphora vicina bilden ein ausgezeichnetes physiologisches Modellsystem um zelluläre Signaltransduktionsprozesse an einem intakten Organ zu untersuchen. Die Speichelsekretion wird dabei hormonell durch das biogene Amin Serotonin (5-Hydroxytryptamin; 5-HT) reguliert. 5-HT aktiviert in den sekretorischen Zellen der Drüsen über die Bindung an mindestens zwei membranständige G-Protein gekoppelte Rezeptoren (GPCR) zwei separate Signalwege, den IP3/Ca2+- und den cAMP-Signalweg.
Zur Identifizierung und Charakterisierung der 5-HT-Rezeptoren in den Speicheldrüsen von Calliphora wurden unter Anwendung verschiedener Klonierungsstrategien zwei cDNAs (Cv5-ht2α und Cv5-ht7) isoliert, die große Ähnlichkeit zu 5-HT2- und 5-HT7-Rezeptoren aus Säugetieren aufweisen. Die Hydropathieprofile der abgeleiteten Aminosäuresequenzen postulieren die für GPCRs charakteristische heptahelikale Architektur. Alle Aminosäuremotive, die für die Ligandenbindung, die Rezeptoraktivierung und die Kopplung an G-Proteine essentiell sind, liegen konserviert vor. Interessanterweise wurde für den Cv5-HT7-Rezeptor eine zusätzliche hydrophobe Domäne im N Terminus vorhergesagt. Die Cv5-HT2α-mRNA liegt in zwei alternativ gespleißten Varianten vor.
Mittels RT-PCR-Experimenten konnte die Expression beider Rezeptoren in Gehirn und Speicheldrüsen adulter Fliegen nachgewiesen werden. Ein Antiserum gegen den Cv5-HT7 Rezeptor markiert in den Speicheldrüsen die basolaterale Plasmamembran.
Die Expression der Rezeptoren in einem heterologen System (HEK 293-Zellen) bestätigte diese als funktionelle 5-HT Rezeptoren. So führte die Stimulation mit Serotonin für den Cv5-HT2α zu einer dosis-abhängigen Erhöhung der intrazellulären Ca2+ Konzentration ([Ca2+]i, EC50 = 24 nM). In Cv5-HT7-exprimierenden Zellen löste 5-HT dosisabhängig (EC50 = 4,1 nM) einen Anstieg der intrazellulären cAMP Konzentration ([cAMP]i) aus. Für beide heterolog exprimierten Rezeptoren wurden pharmakologische Profile erstellt. Liganden, die eine Rezeptorsubtyp-spezifische Wirkung vermuten ließen, wurden daraufhin auf ihre Wirkung auf das transepitheliale Potential (TEP) intakter Speicheldrüsenpräparate getestet. Drei 5-HT-Rezeptoragonisten: AS 19, R-(+)-Lisurid und 5-Carboxamidotryptamin führten zu einer cAMP-abhängigen Positivierung des TEP durch eine selektive Aktivierung der 5 HT7-Rezeptoren. Eine selektive Aktivierung des Ca2+-Signalweges durch den Cv5-HT2 Rezeptor ist mit Hilfe von 5-Methoxytryptamin möglich. Dagegen konnte Clozapin im TEP als selektiver Cv5-HT7-Rezeptorantagonist bestätigt werden.
Die Kombination eines molekularen Ansatzes mit physiologischen Messungen ermöglichte somit die Identifikation selektiver Liganden für 5-HT2- bzw. 5-HT7-Rezeptoren aus Calliphora vicina. Dies ermöglicht zukünftig eine separate Aktivierung der 5-HT-gesteuerten Signalwege und erleichtert dadurch die weitere Erforschung der intrazellulären Signalwege und ihrer Wechselwirkungen.Cellular communication is a fundamental property of living cells and essential for normal functioning of multicellular organisms. The salivary glands of the blowfly Calliphora vicina are a well established physiological model system to study cellular signaling in an intact organ. Fluid secretion in this gland is hormonally regulated by the biogenic amine serotonin (5-hydroxytryptamine, 5-HT). In the secretory cells, 5-HT causes a parallel activation of the InsP3/Ca2+- and the cAMP-signaling pathways through binding and stimulation of at least two G protein coupled receptors (GPCR). In order to characterize the respective 5-HT receptors on the secretory cells, we have cloned two cDNAs (Cv5-ht2α, Cv5-ht7) that share high similarity with mammalian 5-HT2 and 5-HT7 receptor classes. Analysis of the deduced amino acid sequences postulates the typical heptahelical architecture of GPCRs for both receptors. Sequence motifs that are essential for ligand binding, receptor activation and coupling to G-proteins are well conserved. Interestingly, a computer-based structural analysis of Cv5-HT7 predicts an additional eighth hydrophobic region in the N-terminus of the receptor. We also found an alternative splice variant of the Cv5-HT2α mRNA. Using RT-PCR experiments, transcripts of both receptor mRNAs could be detected in brain and salivary gland tissue. An antiserum raised against the Cv5 HT7 receptor stained the basolateral region of the salivary glands. Heterologous receptor expression in HEK 293 cells leads to a dose-dependent increase in the intracellular Ca2+-concentration ([Ca2+]i) for Cv5-HT2α (EC50 = 24 nM) and cAMP-concentration for Cv5-HT7 (EC50 = 4,1 nM) upon application of 5-HT. A pharmacological profile was established for both receptors. Ligands that appeared to act as specific ligands of either Cv5-HT2α or Cv5-HT7 in this approach, were then tested for their effect on the transepithelial potential (TEP) of intact blowfly salivary gland preparations. Three 5-HT receptor agonists: AS 19, R-(+)-lisuride and 5-carboxamidotryptamine showed a cAMP dependent positivation of the TEP, caused by a selective activation of the Cv5-HT7 receptor. 5-methoxytryptamine exclusively activates the Ca2+ pathway via Cv5-HT2α. Clozapine antagonizes the effects of 5-HT in blowfly salivary glands and was confirmed as a Cv5-HT7 antagonist. The combination of a molecular approach with physiological measurements enabled us to identify selective ligands for 5-HT2 and 5-HT7 receptors of Calliphora vicina. These results facilitate a selective activation of the intracellular signaling pathways activated by 5-HT and will facilitate future research on different aspects of intracellular signaling and crosstalk mechanisms.
47
Ramsay, Andrew John. "Kallikrein-related peptidase 4 activation of protease-activated receptor family members and association with prostate cancer." Thesis, Queensland University of Technology, 2008. https://eprints.qut.edu.au/29886/1/Andrew_Ramsay_Thesis.pdf.
Full textAbstract:
Two areas of particular importance in prostate cancer progression are primary tumour development and metastasis. These processes involve a number of physiological events, the mediators of which are still being discovered and characterised. Serine proteases have been shown to play a major role in cancer invasion and metastasis. The recently discovered phenomenon of their activation of a receptor family known as the protease activated receptors (PARs) has extended their physiological role to that of signaling molecule. Several serine proteases are expressed by malignant prostate cancer cells, including members of the kallikreinrelated peptidase (KLK) serine protease family, and increasingly these are being shown to be associated with prostate cancer progression. KLK4 is highly expressed in the prostate and expression levels increase during prostate cancer progression. Critically, recent studies have implicated KLK4 in processes associated with cancer. For example, the ectopic over-expression of KLK4 in prostate cancer cell lines results in an increased ability of these cells to form colonies, proliferate and migrate. In addition, it has been demonstrated that KLK4 is a potential mediator of cellular interactions between prostate cancer cells and osteoblasts (bone forming cells). The ability of KLK4 to influence cellular behaviour is believed to be through the selective cleavage of specific substrates. Identification of relevant in vivo substrates of KLK4 is critical to understanding the pathophysiological roles of this enzyme. Significantly, recent reports have demonstrated that several members of the KLK family are able to activate PARs. The PARs are relatively new members of the seven transmembrane domain containing G protein coupled receptor (GPCR) family. PARs are activated through proteolytic cleavage of their N-terminus by serine proteases, the resulting nascent N-terminal binds intramolecularly to initiate receptor activation. PARs are involved in a number of patho-physiological processes, including vascular repair and inflammation, and a growing body of evidence suggests roles in cancer. While expression of PAR family members has been documented in several types of cancers, including prostate, the role of these GPCRs in prostate cancer development and progression is yet to be examined. Interestingly, several studies have suggested potential roles in cellular invasion through the induction of cytoskeletal reorganisation and expression of basement membrane-degrading enzymes. Accordingly, this program of research focussed on the activation of the PARs by the prostate cancer associated enzyme KLK4, cellular processing of activated PARs and the expression pattern of receptor and agonist in prostate cancer. For these studies KLK4 was purified from the conditioned media of stably transfected Sf9 insect cells expressing a construct containing the complete human KLK4 coding sequence in frame with a V5 epitope and poly-histidine encoding sequences. The first aspect of this study was the further characterisation of this recombinant zymogen form of KLK4. The recombinant KLK4 zymogen was demonstrated to be activatable by the metalloendopeptidase thermolysin and amino terminal sequencing indicated that thermolysin activated KLK4 had the predicted N-terminus of mature active KLK4 (31IINED). Critically, removal of the pro-region successfully generated a catalytically active enzyme, with comparable activity to a previously published recombinant KLK4 produced from S2 insect cells. The second aspect of this study was the activation of the PARs by KLK4 and the initiation of signal transduction. This study demonstrated that KLK4 can activate PAR-1 and PAR-2 to mobilise intracellular Ca2+, but failed to activate PAR-4. Further, KLK4 activated PAR-1 and PAR-2 over distinct concentration ranges, with KLK4 activation and mobilisation of Ca2+ demonstrating higher efficacy through PAR-2. Thus, the remainder of this study focussed on PAR-2. KLK4 was demonstrated to directly cleave a synthetic peptide that mimicked the PAR-2 Nterminal activation sequence. Further, KLK4 mediated Ca2+ mobilisation through PAR-2 was accompanied by the initiation of the extra-cellular regulated kinase (ERK) cascade. The specificity of intracellular signaling mediated through PAR-2 by KLK4 activation was demonstrated by siRNA mediated protein depletion, with a reduction in PAR-2 protein levels correlating to a reduction in KLK4 mediated Ca2+mobilisation and ERK phosphorylation. The third aspect of this study examined cellular processing of KLK4 activated PAR- 2 in a prostate cancer cell line. PAR-2 was demonstrated to be expressed by five prostate derived cell lines including the prostate cancer cell line PC-3. It was also demonstrated by flow cytometry and confocal microscopy analyses that activation of PC-3 cell surface PAR-2 by KLK4 leads to internalisation of this receptor in a time dependent manner. Critically, in vivo relevance of the interaction between KLK4 and PAR-2 was established by the observation of the co-expression of receptor and agonist in primary prostate cancer and prostate cancer bone lesion samples by immunohistochemical analysis. Based on the results of this study a number of exciting future studies have been proposed, including, delineating differences in KLK4 cellular signaling via PAR-1 and PAR-2 and the role of PAR-1 and PAR-2 activation by KLK4 in prostate cancer cells and bone cells in prostate cancer progression.
48
Ramsay, Andrew John. "Kallikrein-related peptidase 4 activation of protease-activated receptor family members and association with prostate cancer." Queensland University of Technology, 2008. http://eprints.qut.edu.au/29886/.
Full textAbstract:
Two areas of particular importance in prostate cancer progression are primary tumour development and metastasis. These processes involve a number of physiological events, the mediators of which are still being discovered and characterised. Serine proteases have been shown to play a major role in cancer invasion and metastasis. The recently discovered phenomenon of their activation of a receptor family known as the protease activated receptors (PARs) has extended their physiological role to that of signaling molecule. Several serine proteases are expressed by malignant prostate cancer cells, including members of the kallikreinrelated peptidase (KLK) serine protease family, and increasingly these are being shown to be associated with prostate cancer progression. KLK4 is highly expressed in the prostate and expression levels increase during prostate cancer progression. Critically, recent studies have implicated KLK4 in processes associated with cancer. For example, the ectopic over-expression of KLK4 in prostate cancer cell lines results in an increased ability of these cells to form colonies, proliferate and migrate. In addition, it has been demonstrated that KLK4 is a potential mediator of cellular interactions between prostate cancer cells and osteoblasts (bone forming cells). The ability of KLK4 to influence cellular behaviour is believed to be through the selective cleavage of specific substrates. Identification of relevant in vivo substrates of KLK4 is critical to understanding the pathophysiological roles of this enzyme. Significantly, recent reports have demonstrated that several members of the KLK family are able to activate PARs. The PARs are relatively new members of the seven transmembrane domain containing G protein coupled receptor (GPCR) family. PARs are activated through proteolytic cleavage of their N-terminus by serine proteases, the resulting nascent N-terminal binds intramolecularly to initiate receptor activation. PARs are involved in a number of patho-physiological processes, including vascular repair and inflammation, and a growing body of evidence suggests roles in cancer. While expression of PAR family members has been documented in several types of cancers, including prostate, the role of these GPCRs in prostate cancer development and progression is yet to be examined. Interestingly, several studies have suggested potential roles in cellular invasion through the induction of cytoskeletal reorganisation and expression of basement membrane-degrading enzymes. Accordingly, this program of research focussed on the activation of the PARs by the prostate cancer associated enzyme KLK4, cellular processing of activated PARs and the expression pattern of receptor and agonist in prostate cancer. For these studies KLK4 was purified from the conditioned media of stably transfected Sf9 insect cells expressing a construct containing the complete human KLK4 coding sequence in frame with a V5 epitope and poly-histidine encoding sequences. The first aspect of this study was the further characterisation of this recombinant zymogen form of KLK4. The recombinant KLK4 zymogen was demonstrated to be activatable by the metalloendopeptidase thermolysin and amino terminal sequencing indicated that thermolysin activated KLK4 had the predicted N-terminus of mature active KLK4 (31IINED). Critically, removal of the pro-region successfully generated a catalytically active enzyme, with comparable activity to a previously published recombinant KLK4 produced from S2 insect cells. The second aspect of this study was the activation of the PARs by KLK4 and the initiation of signal transduction. This study demonstrated that KLK4 can activate PAR-1 and PAR-2 to mobilise intracellular Ca2+, but failed to activate PAR-4. Further, KLK4 activated PAR-1 and PAR-2 over distinct concentration ranges, with KLK4 activation and mobilisation of Ca2+ demonstrating higher efficacy through PAR-2. Thus, the remainder of this study focussed on PAR-2. KLK4 was demonstrated to directly cleave a synthetic peptide that mimicked the PAR-2 Nterminal activation sequence. Further, KLK4 mediated Ca2+ mobilisation through PAR-2 was accompanied by the initiation of the extra-cellular regulated kinase (ERK) cascade. The specificity of intracellular signaling mediated through PAR-2 by KLK4 activation was demonstrated by siRNA mediated protein depletion, with a reduction in PAR-2 protein levels correlating to a reduction in KLK4 mediated Ca2+mobilisation and ERK phosphorylation. The third aspect of this study examined cellular processing of KLK4 activated PAR- 2 in a prostate cancer cell line. PAR-2 was demonstrated to be expressed by five prostate derived cell lines including the prostate cancer cell line PC-3. It was also demonstrated by flow cytometry and confocal microscopy analyses that activation of PC-3 cell surface PAR-2 by KLK4 leads to internalisation of this receptor in a time dependent manner. Critically, in vivo relevance of the interaction between KLK4 and PAR-2 was established by the observation of the co-expression of receptor and agonist in primary prostate cancer and prostate cancer bone lesion samples by immunohistochemical analysis. Based on the results of this study a number of exciting future studies have been proposed, including, delineating differences in KLK4 cellular signaling via PAR-1 and PAR-2 and the role of PAR-1 and PAR-2 activation by KLK4 in prostate cancer cells and bone cells in prostate cancer progression.
49
Mohammed, Kader Hamno. "Development of a label-free biosensor method for the identification of sticky compounds which disturb GPCR-assays." Thesis, Uppsala universitet, Institutionen för biologisk grundutbildning, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-220645.
Full textAbstract:
It is widely known that early estimates about the binding properties of drug candidates are important in the drug discovery process. Surface plasmon resonance (SPR) biosensors have become a standard tool for characterizing interactions between a great variety of biomolecules and it offers a unique opportunity to study binding activity. The aim of this project was to develop a SPR based assay for pre-screening of low molecular weight (LMW) drug compounds, to enable filtering away disturbing compounds when interacting with drugs. The interaction between 47 LMW compounds and biological ligands were investigated using the instrument BiacoreTM, which is based on SPR-technology.
50
Dupuis, Julien. "Couplage fonctionnel entre un récepteur et un canal ionique : étude du canal KATP et application pour la création de biocapteurs." Phd thesis, Grenoble 1, 2008. http://www.theses.fr/2008GRE10108.
Full textAbstract:
Les canaux potassiques sensibles à l'ATP (KATP) jouent un rôle primordial dans la sécrétion pancréatique d'insuline et participent au contrôle du tonus vasculaire ainsi que de l'excitabilité des cellules musculaires cardiaques et neuronales. Constitués de l'assemblage unique d'un récepteur membranaire de la famille des transporteurs ABC, le récepteur des sulphonylurées SUR, et d'un canal potassique rectifiant entrant, Kir6. 2, ces canaux couplent le métabolisme cellulaire au potentiel membranaire et constituent en ce sens un modèle naturel de biocapteur. Le caractère unique de cet assemblage tient au fait que SUR est capable de réguler l'activité de Kir6. 2 suite à la fixation de ligands: nucléotides, activateurs ou inhibiteurs pharmacologiques. Nous nous sommes intéressés aux déterminants moléculaires intervenant dans le couplage fonctionnel de SUR au canal Kir6. 2. Utilisant une stratégie chimérique, nous avons identifié une région C-terminale de l'isoforme SUR2A essentielle aux mécanismes d'activation du canal, assurant le lien entre la fixation de ligands à SUR et l'ouverture de Kir6. 2. Nous avons également utilisé notre connaissance du modèle du canal KATP pour développer un nouveau type de biocapteur électrique, les Ion Channel Coupled Receptors (ICCR), fondé sur le couplage fonctionnel artificiel entre Kir6. 2 et des récepteurs couplés aux protéines G (GPCR). Par ingénierie protéique, nous avons créé deux modèles d'ICCR impliquant respectivement les récepteurs muscarinique M2 et dopaminergique D2 : la fixation d'agonistes ou antagonistes spécifiques sur ces récepteurs entraîne une activation ou une inhibition du canal mesurables électriquement en temps réel, jetant les bases prometteuses d'une nouvelle génération de biocapteurs acellulairesATP-sensitive potassium channels (KATP) play a critical role in pancreatic insulin secretion and participate in the vascular tone control as well as cardiac myocyte and neuron excitability. Formed by the unique association of a membrane receptor of the ABC transporters family, the sulfonylurea receptor SUR, and an inward rectifier potassium channel, Kir6. 2, they couple the membrane potential to the cell metabolism. Therefore, they can be considered as a natural example of biosensor. The unique property of this complex is that SUR adjusts Kir6. 2 gating as a function of physiological and pharmacological ligands (nucleotides, synthetic activators and inhibitors). We addressed the question of identifying the molecular elements underlying functional coupling between SUR and Kir6. 2. Following a chimerical strategy, we identified an essential C-terminal region of isoform SUR2A which functionally links ligand binding to SUR to Kir6. 2 upregulation. Using our knowledge of the KATP model, we also developed a new type of electrical biosensor, Ion Channel Coupled Receptors (ICCRs), based on the artificial functional coupling of Kir6. 2 with G-protein coupled receptors (GPCRs). Using protein engineering, we created two prototypes of ICCRs based on the muscarinic M2 and dopaminergic D2 receptors: agonist or antagonist binding to these receptors leads to real-time electrically measurable channel activations or inhibitions. ICCRs constitute the promising premises of a new generation of cell-free biosensors